Query 018141
Match_columns 360
No_of_seqs 189 out of 1900
Neff 10.5
Searched_HMMs 46136
Date Fri Mar 29 06:29:16 2013
Command hhsearch -i /work/01045/syshi/csienesis_hhblits_a3m/018141.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/018141hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 COG0534 NorM Na+-driven multid 100.0 1.4E-49 3E-54 366.5 42.6 355 1-358 91-449 (455)
2 PRK10189 MATE family multidrug 100.0 2.3E-45 5E-50 341.5 44.2 354 1-356 103-466 (478)
3 PRK00187 multidrug efflux prot 100.0 3.9E-45 8.5E-50 339.8 44.0 348 1-350 84-442 (464)
4 PRK01766 multidrug efflux prot 100.0 1.5E-43 3.2E-48 330.0 43.2 355 1-357 86-447 (456)
5 PRK09575 vmrA multidrug efflux 100.0 1.5E-43 3.3E-48 328.7 41.5 346 1-351 87-435 (453)
6 PRK10367 DNA-damage-inducible 100.0 1.1E-42 2.4E-47 320.6 42.2 346 1-356 84-434 (441)
7 TIGR01695 mviN integral membra 100.0 2.2E-34 4.8E-39 272.2 40.6 340 3-352 78-428 (502)
8 PRK15099 O-antigen translocase 100.0 2E-31 4.4E-36 245.7 39.4 332 2-350 76-410 (416)
9 TIGR02900 spore_V_B stage V sp 100.0 1.2E-31 2.6E-36 252.7 38.0 343 1-352 75-434 (488)
10 TIGR00797 matE putative efflux 100.0 5.5E-31 1.2E-35 236.9 33.7 272 1-274 67-341 (342)
11 PF03023 MVIN: MviN-like prote 100.0 1.2E-28 2.6E-33 227.7 42.4 340 3-352 53-403 (451)
12 KOG1347 Uncharacterized membra 100.0 2.4E-30 5.2E-35 237.0 24.2 356 1-358 103-458 (473)
13 COG0728 MviN Uncharacterized m 100.0 1.3E-24 2.8E-29 198.0 40.5 337 9-353 93-438 (518)
14 PRK10459 colanic acid exporter 100.0 1.8E-24 3.9E-29 203.9 38.7 329 3-351 74-404 (492)
15 COG0534 NorM Na+-driven multid 99.9 2.2E-25 4.8E-30 205.9 26.9 209 142-353 12-222 (455)
16 PRK00187 multidrug efflux prot 99.9 5.5E-25 1.2E-29 204.9 27.2 206 142-351 5-214 (464)
17 PRK10367 DNA-damage-inducible 99.9 5.1E-25 1.1E-29 203.4 26.6 207 143-351 5-211 (441)
18 PRK10189 MATE family multidrug 99.9 8.9E-25 1.9E-29 203.7 26.9 205 143-350 25-235 (478)
19 PRK09575 vmrA multidrug efflux 99.9 1.3E-24 2.8E-29 202.1 25.4 208 142-352 7-215 (453)
20 PRK01766 multidrug efflux prot 99.9 1.7E-23 3.7E-28 195.3 27.8 209 142-353 7-219 (456)
21 COG2244 RfbX Membrane protein 99.9 2.8E-20 6E-25 175.1 33.7 278 46-335 118-395 (480)
22 TIGR00797 matE putative efflux 99.9 9.8E-20 2.1E-24 163.8 24.8 194 155-351 1-196 (342)
23 PF01554 MatE: MatE; InterPro 99.8 2.3E-21 4.9E-26 155.1 8.0 162 155-318 1-162 (162)
24 TIGR02900 spore_V_B stage V sp 99.6 1.1E-13 2.5E-18 130.6 21.1 197 150-352 2-204 (488)
25 KOG1347 Uncharacterized membra 99.6 1.7E-13 3.7E-18 126.3 20.8 206 143-352 24-230 (473)
26 TIGR01695 mviN integral membra 99.5 4.5E-12 9.8E-17 120.1 22.9 197 149-352 2-207 (502)
27 PF01943 Polysacc_synt: Polysa 99.5 4.4E-11 9.5E-16 103.8 23.9 154 56-216 120-273 (273)
28 PRK15099 O-antigen translocase 99.4 4.4E-11 9.4E-16 110.6 19.4 191 150-350 4-195 (416)
29 PF13440 Polysacc_synt_3: Poly 99.3 6.2E-09 1.3E-13 89.2 25.2 159 46-215 92-251 (251)
30 PF03023 MVIN: MviN-like prote 99.3 8.6E-10 1.9E-14 102.5 20.7 173 176-353 4-183 (451)
31 COG0728 MviN Uncharacterized m 99.0 1.3E-07 2.8E-12 87.4 23.1 206 142-352 6-216 (518)
32 PF04506 Rft-1: Rft protein; 98.8 6E-06 1.3E-10 77.9 24.3 204 146-351 252-469 (549)
33 PF01554 MatE: MatE; InterPro 98.7 1.2E-08 2.6E-13 81.2 2.8 94 1-94 67-162 (162)
34 KOG2864 Nuclear division RFT1 98.7 8.7E-05 1.9E-09 66.2 26.4 295 54-351 132-448 (530)
35 PF14667 Polysacc_synt_C: Poly 98.5 3.2E-05 6.9E-10 60.3 17.6 77 48-126 2-78 (146)
36 PF14667 Polysacc_synt_C: Poly 98.5 8.9E-07 1.9E-11 69.1 8.5 79 271-352 2-80 (146)
37 PF01943 Polysacc_synt: Polysa 98.4 9.3E-05 2E-09 64.0 21.6 187 151-351 3-190 (273)
38 PRK10459 colanic acid exporter 98.4 3.5E-05 7.6E-10 73.0 20.3 184 147-347 5-189 (492)
39 PF13440 Polysacc_synt_3: Poly 98.2 0.00093 2E-08 57.0 21.4 164 170-350 7-171 (251)
40 PF07260 ANKH: Progressive ank 97.9 0.0082 1.8E-07 51.6 20.4 171 142-319 6-179 (345)
41 COG2244 RfbX Membrane protein 97.8 0.0012 2.7E-08 62.3 17.4 186 147-349 6-193 (480)
42 PF07260 ANKH: Progressive ank 97.6 0.03 6.5E-07 48.3 19.3 159 33-192 117-284 (345)
43 PF04506 Rft-1: Rft protein; 97.0 0.038 8.3E-07 52.6 15.3 124 3-127 342-469 (549)
44 KOG2864 Nuclear division RFT1 96.3 0.45 9.7E-06 43.4 16.3 123 2-126 321-447 (530)
45 COG4267 Predicted membrane pro 90.2 13 0.00029 33.4 24.3 264 64-342 150-436 (467)
46 COG4267 Predicted membrane pro 82.5 38 0.00081 30.7 20.9 139 196-351 72-210 (467)
47 PF04505 Dispanin: Interferon- 64.5 25 0.00053 24.1 5.2 41 202-242 34-74 (82)
48 PF06808 DctM: DctM-like trans 58.8 1.6E+02 0.0034 27.5 14.0 80 140-242 203-282 (416)
49 PF14184 YrvL: Regulatory prot 50.8 1.1E+02 0.0023 23.2 12.7 91 6-98 4-95 (132)
50 PF03904 DUF334: Domain of unk 38.4 1.8E+02 0.0039 24.3 6.9 56 4-59 148-212 (230)
51 PF04138 GtrA: GtrA-like prote 35.3 1.7E+02 0.0037 21.1 11.7 75 82-166 7-81 (117)
52 PF13347 MFS_2: MFS/sugar tran 31.9 4.1E+02 0.0089 24.4 17.0 222 69-317 134-373 (428)
53 PF14184 YrvL: Regulatory prot 30.7 2.4E+02 0.0052 21.4 12.6 111 231-345 7-118 (132)
54 TIGR00383 corA magnesium Mg(2+ 28.8 2.7E+02 0.0058 24.6 7.4 19 336-354 299-317 (318)
55 COG1173 DppC ABC-type dipeptid 25.4 4.6E+02 0.01 23.0 8.1 60 53-112 98-157 (289)
56 PRK15060 L-dehydroascorbate tr 24.5 5.9E+02 0.013 23.8 16.0 79 142-243 205-283 (425)
57 PRK11085 magnesium/nickel/coba 23.6 3E+02 0.0066 24.5 6.5 16 339-354 300-315 (316)
58 PF05975 EcsB: Bacterial ABC t 21.2 6.4E+02 0.014 23.1 15.8 37 1-37 92-130 (386)
No 1
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=100.00 E-value=1.4e-49 Score=366.51 Aligned_cols=355 Identities=26% Similarity=0.409 Sum_probs=335.6
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
++++..+++++++++++++.+++ +.+.+|++.+++.++|+.+.+.+|+++..++.|+..+....++.+|++||+|.+++
T Consensus 91 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~m~ 170 (455)
T COG0534 91 KAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKTPMY 170 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchhHH
Confidence 46789999999999999888876 99999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhh-cC-CCcchhHHHHHHHHHHHHHHHHHHHHhccc-cccccCCCCHHhHHhHHHHHHhHhHh
Q 018141 80 FSALPMAIHFGIAYAFVYL-TS-LGFKGASLAASVSLWISMLMLVTYVLCAKK-FEHTWEGFSFESFSFILTILKLALPS 156 (360)
Q Consensus 80 ~~~~~~~~~i~l~~~~i~~-~~-~g~~g~ala~~i~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~p~ 156 (360)
.++++.++|+++|++++++ ++ +|+.|+++||++++.++.++.++++.++++ ......+..+.+++.+|++++.|+|.
T Consensus 171 ~~~~~~~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~lG~p~ 250 (455)
T COG0534 171 ILLLGNLLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLLLIYLLRKKRLLSLFKKKLLKPDRKLLKEILRLGLPI 250 (455)
T ss_pred HHHHHHHHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhccCCCHHHHHHHHHhcccH
Confidence 9999999999999999999 57 999999999999999999999999977664 22232334345689999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHH
Q 018141 157 AAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSV 236 (360)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 236 (360)
.+++..........+.+++++| ++++|+|+++.++.++.++++.|++++.+|+++|++|+||+|++|+..+.+.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~G--~~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvG~~~Ga~~~~~a~~~~~~~~~~~~ 328 (455)
T COG0534 251 FLESLSESLGFLLLTLFVARLG--TVALAAYGIALRIASFIFMPPFGIAQAVTILVGQNLGAGNYKRARRAARLALKLSL 328 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHhcC--hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHH
Confidence 9999999999999999999998 99999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHH
Q 018141 237 LLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIA 316 (360)
Q Consensus 237 ~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~ 316 (360)
.++...+.+++++++++.++|++|+|+.+.+.+++++.++..++++.+....+.+||.||+|.++..++.+.|.+.+|+.
T Consensus 329 ~~~~~~~~i~~~f~~~i~~lF~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~g~lrg~g~~~~~~~~~~~~~~~~~lp~~ 408 (455)
T COG0534 329 LIALLIALLLLLFREPIISLFTTDPEVIALAVILLLIAALFQPFDGIQFVLSGVLRGAGDAKIPFIISLLSYWGFRLPLA 408 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCcHHHHHHHHHHHHHHHHhHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhccCchhhh
Q 018141 317 AILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRRKWTKVD 358 (360)
Q Consensus 317 ~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (360)
+++.... +|..|+|++...++.+..+...++++|.+|+++.
T Consensus 409 ~~l~~~~-~g~~Gvw~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (455)
T COG0534 409 YLLGFFF-LGLAGVWIGFPLSLILRAILLLLRLRRGRWRRKA 449 (455)
T ss_pred HHHhhhc-ccchHHHHHHHHHHHHHHHHHHHHHHHhhhhhhh
Confidence 9997765 8999999999999999999999999999998754
No 2
>PRK10189 MATE family multidrug exporter; Provisional
Probab=100.00 E-value=2.3e-45 Score=341.47 Aligned_cols=354 Identities=16% Similarity=0.222 Sum_probs=325.5
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcC--CChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLH--QDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPL 77 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~--~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~ 77 (360)
+++++.++++.++...+++.+++ +.+.+|++.+++ .|+|+.+.+.+|+++..++.|+..+....++++|+.||++.+
T Consensus 103 ~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~ 182 (478)
T PRK10189 103 RARAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRGAGNTKIP 182 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCchHHh
Confidence 46789999999999999998887 778899999984 699999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHhhhc----CCCcchhHHHHHHHHHHHHHHHHHHHHhccc--cccccCC-CCHHhHHhHHHHH
Q 018141 78 IFFSALPMAIHFGIAYAFVYLT----SLGFKGASLAASVSLWISMLMLVTYVLCAKK--FEHTWEG-FSFESFSFILTIL 150 (360)
Q Consensus 78 ~~~~~~~~~~~i~l~~~~i~~~----~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~l 150 (360)
+..+++..++|+++|++++++. ++|+.|+++|+.+++.+..++..++++++++ .+.++++ +.+.+++.+|+++
T Consensus 183 ~~i~~~~~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il 262 (478)
T PRK10189 183 LLINGGMNILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAIIWVLMIGFNPALRISLKSYFKPLNFAIIWEVM 262 (478)
T ss_pred HHHHHHHHHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHHHHHHHhccCccceeeeccccccCCHHHHHHHH
Confidence 9999999999999999999863 7999999999999999998887666654322 2222222 2223578999999
Q ss_pred HhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHH
Q 018141 151 KLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAV 230 (360)
Q Consensus 151 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~ 230 (360)
+.|.|..++...........+.+++++| ++++|+++++.++.++..++..|++++..|+++|++|+||+|++|+..+.
T Consensus 263 ~iG~P~~~~~~~~~~~~~~~~~~~~~~G--~~~~Aa~~I~~~i~~~~~~~~~gi~~A~~~lvg~~~Ga~~~~~a~~~~~~ 340 (478)
T PRK10189 263 GIGIPASIESVLFNGGKLLTQMFVAGMG--TSVIAGNFIAFSIAALINLPGNALGSASTIITGTRLGKGQIAQAERQLRH 340 (478)
T ss_pred HHhccHHHHHHHHHHHHHHHHHHHHHcC--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHH
Confidence 9999999999999998888888899988 88999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHH
Q 018141 231 TVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYF 310 (360)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~ 310 (360)
+.+++.+.+..++++++++++++.++|++|+|+.+.+..++++.+...++++.+....+.+||.||++.+++.++.+.|+
T Consensus 341 ~~~~~~~~~~~~~~l~~~~~~~i~~lFt~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~g~lrg~G~t~~~~~i~~~~~~~ 420 (478)
T PRK10189 341 VFWLSTLGLTAIAWLSAPFAGLLASFYTQDPDVKHVVKILIWLNALFMPIWAASWVLPAGLKGARDARYAMWVSMLGMWG 420 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhHhhcCCCchHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhccCchh
Q 018141 311 IGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRRKWTK 356 (360)
Q Consensus 311 ~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~~~~~ 356 (360)
+.+|..+++....++|+.|+|++..+++.+..++..+++++.+|++
T Consensus 421 v~ip~~~ll~~~~~~g~~Gvw~~~~~~~~~~~~~~~~r~~~~~W~~ 466 (478)
T PRK10189 421 CRVVAGYILGIMLGFGVVGVWMGMFLDWAVRGVLFYWRMVSGRWLW 466 (478)
T ss_pred HHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHcCcccc
Confidence 9999999998778899999999999999999999999999999987
No 3
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=100.00 E-value=3.9e-45 Score=339.79 Aligned_cols=348 Identities=23% Similarity=0.316 Sum_probs=316.1
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFLWIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFF 80 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 80 (360)
++++++++++.++.+++++.+++..+.+|++.+++.|+|+.+.+.+|+++..++.|+..+....++++|+.||++.+++.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~~ 163 (464)
T PRK00187 84 GATRLAQAGLWLAWLLALVAALLLWNLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVMVI 163 (464)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHHH
Confidence 46889999999999999988877667899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHhhhc----CCCcchhHHHHHHHHHHHHHHHHHHHHhcccc-ccc-cCCCCHHhHHhHHHHHHhHh
Q 018141 81 SALPMAIHFGIAYAFVYLT----SLGFKGASLAASVSLWISMLMLVTYVLCAKKF-EHT-WEGFSFESFSFILTILKLAL 154 (360)
Q Consensus 81 ~~~~~~~~i~l~~~~i~~~----~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~l~~~~ 154 (360)
+++..++|+++|+++++++ ++|+.|+++|+.+++....+.+.++++++++. +.+ +.+..+.+++..|++++.++
T Consensus 164 ~~~~~~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~lg~ 243 (464)
T PRK00187 164 SLAGAVANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMALALALYIRRHPAYAAYPLRKGLSRPSRAALRELWRLGL 243 (464)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHHHHHHHHHHhcchhhhhhhhccccCCCHHHHHHHHHhhh
Confidence 9999999999999999863 58999999999999988887776666544322 112 11222345788999999999
Q ss_pred HhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHH
Q 018141 155 PSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKL 234 (360)
Q Consensus 155 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~ 234 (360)
|.++++..+.....+++.+++++| ++++|++++++++..+..++..|++++..+.++|++|+||+|++++..+++..+
T Consensus 244 P~~~~~~~~~~~~~i~~~~i~~~G--~~alAa~~i~~~i~~l~~~~~~gi~~a~~~lvgq~~Ga~~~~~~~~~~~~~l~~ 321 (464)
T PRK00187 244 PIGGTYAVEVGLFTFAALCMGALG--STQLAAHQIALQIVSVAFMVPVGLSYAVTMRVGQHYGAGRLLEARRAGRVGIGF 321 (464)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHcC--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHH
Confidence 999999999999999999999998 889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhhccccCC--cH---HHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHH
Q 018141 235 SVLLALVVVLALGFGHNIWAGFFSN--SP---EIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFY 309 (360)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~i~~l~~~--~~---~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~ 309 (360)
+.+++++.+++++++++++.++|++ |+ |+.+.+..++++.+.+.++++++....+.+||.||++.+++.++.+.|
T Consensus 322 ~~~~~~~~~~~~~~f~~~i~~~ft~~~~~~~~~v~~~~~~~l~i~~~~~~~~~~~~v~~~~lrg~G~~~~~~~~~~~~~~ 401 (464)
T PRK00187 322 GAVVMLLFAGLFWLLPEAIIGLFLDRNDPAFAEIVQLAVSLLAVAAWFELFDGTQTIAMGAIRGLKDARTTFLIGLACYW 401 (464)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCCCCccHHHHHHHHHHHHHHHHHHHhhHHHHHHHHhHhccCccHHHHHHHHHHHH
Confidence 9999999999999999999999964 43 788999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHh
Q 018141 310 FIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITL 350 (360)
Q Consensus 310 ~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~ 350 (360)
++++|.++++.+.+++|+.|+|+++.+++.+..+....+++
T Consensus 402 ~~~ipl~~ll~~~~~~g~~Gvw~~~~i~~~~~~~~~~~~~~ 442 (464)
T PRK00187 402 LVGAPLAWLLAFTLGWGAVGVWWGLALGLACAAVALTLAFE 442 (464)
T ss_pred HHHHHHHHHHHhccCCCceeeHHHHHHHHHHHHHHHHHHHH
Confidence 99999999998888899999999999999999887655543
No 4
>PRK01766 multidrug efflux protein; Reviewed
Probab=100.00 E-value=1.5e-43 Score=330.05 Aligned_cols=355 Identities=24% Similarity=0.417 Sum_probs=326.0
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
++++.+++++.++++.+++++++ ..+.++++.+++.|+|+.+.+.+|+++..++.|+..+....++++|+.||++.+++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 165 (456)
T PRK01766 86 RIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPTMV 165 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHH
Confidence 36789999999999999988876 77779999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhh----cCCCcchhHHHHHHHHHHHHHHHHHHHHhccccc-c-ccCCCCHHhHHhHHHHHHhH
Q 018141 80 FSALPMAIHFGIAYAFVYL----TSLGFKGASLAASVSLWISMLMLVTYVLCAKKFE-H-TWEGFSFESFSFILTILKLA 153 (360)
Q Consensus 80 ~~~~~~~~~i~l~~~~i~~----~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~l~~~ 153 (360)
.+.++.++|+++|++++++ +++|+.|+++++.+++.+..++..++++++++.+ . .+.++.+.+++..|++++.+
T Consensus 166 ~~~i~~ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~il~l~ 245 (456)
T PRK01766 166 IGFLGLLINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRARRFRDFRLFKGLYKPDWAVIKRLLKLG 245 (456)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhChhhhHHHhhccccCCCHHHHHHHHHcc
Confidence 9999999999999999975 3689999999999999999998888776544321 1 12222334578899999999
Q ss_pred hHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHH
Q 018141 154 LPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVK 233 (360)
Q Consensus 154 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~ 233 (360)
+|.++++..+...+..++.+++++| ++++++++++.++.++..+++.|++++..+.++|++|+||++++|+..+.+.+
T Consensus 246 ~P~~~~~~~~~~~~~~~~~~~~~~G--~~~lAa~~i~~~i~~~~~~~~~gl~~a~~~~v~~~~Ga~~~~~~~~~~~~~~~ 323 (456)
T PRK01766 246 LPIGLAIFFEVSLFAVVTLLVSPLG--TVTVAAHQIALNFSSLLFMLPLSLAMALTIRVGFELGAGRTLDARQYAYIGLA 323 (456)
T ss_pred chHHHHHHHHHHHHHHHHHHHHHcC--hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCHHHHHHHHHHHHH
Confidence 9999999999999999999999988 88999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHH
Q 018141 234 LSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGM 313 (360)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i 313 (360)
++..++++.+++++.+++++.++|++|+|+.+.+..++++.++..++++++....+.+||.||++.+++.++.+.|++++
T Consensus 324 ~~~~~~~~~~~~~~~~~~~i~~lf~~d~~v~~~~~~~l~~~~~~~~~~~~~~~~~~~l~g~g~~~~~~~~~~~~~~~~~i 403 (456)
T PRK01766 324 VGLGMALLTAIFLVLFREQIALLYTDDPEVVALASHLLLFAALFQFSDAIQVIGSGALRGYKDTRVIFFITFIAYWVLGL 403 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHhchhccCccHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999889999
Q ss_pred HHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhccCchhh
Q 018141 314 PIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRRKWTKV 357 (360)
Q Consensus 314 ~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~~~~~~ 357 (360)
|..+++...+++|+.|+|+++.+++.+..++..+++++.+|+..
T Consensus 404 ~~~~~l~~~~~~G~~G~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (456)
T PRK01766 404 PLGYILALTDPMGPFGFWIGLIIGLTAAAILLLLRLRKLQRQPS 447 (456)
T ss_pred HHHHHHHhccCCCceehHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 99999988888999999999999999999999888888877743
No 5
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=100.00 E-value=1.5e-43 Score=328.67 Aligned_cols=346 Identities=18% Similarity=0.197 Sum_probs=314.8
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
++++.+++++.++.+.+++..++ ..+.+|++.+++.|+|+.+.+.+|+++..++.|+..+.....+.+|+.||++.++.
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~~ 166 (453)
T PRK09575 87 KAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPNLATG 166 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHHHH
Confidence 46889999999999999999887 88899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhcccc-ccccCCCCHHhHHhHHHHHHhHhHhHH
Q 018141 80 FSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKF-EHTWEGFSFESFSFILTILKLALPSAA 158 (360)
Q Consensus 80 ~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~p~~~ 158 (360)
.++...++|+.+|+++++.+++|+.|+++|+.+++.+..++.+++.+++++. +.+.++ .+.+++..|++++.|.|..+
T Consensus 167 ~~~~~~~~ni~l~~~li~~~~~Gi~Gaa~At~is~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~il~ig~P~~~ 245 (453)
T PRK09575 167 LMVIGALINIVLDYLFIGWLDWGLTGAAIATALAQLVVTVLGLGYFFSSRANIRLTLKE-LRFNWSLAPKIVLLGSSSFF 245 (453)
T ss_pred HHHHHHHHHHHhhHHHHHhCCchhHHHHHHHHHHHHHHHHHHHHHHHCCCceeEEeecc-CCcCHHHHHHHHHhChhHHH
Confidence 9999999999999999998899999999999999999999887777544332 222222 23457889999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHH
Q 018141 159 MVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLL 238 (360)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (360)
++........+.+.+.+++| ++.++|+++++.++..+..++..|++++..|.+||++|+||+|++++..+++.+++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~g-~~~~lAa~~i~~~i~~~~~~~~~gi~~a~~~lvg~~~Ga~~~~~~~~~~~~~l~l~~~~ 324 (453)
T PRK09575 246 MYLYGSFVVALHNRLFMEYG-SALTVGAYAIVGYLMVLYYLVAEGIAEGMQPPVSYYFGARQYDNIKKLLKLAMKVTVLA 324 (453)
T ss_pred HHHHHHHHHHHHHHHHHHhC-chHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHhcCCChHHHHHHHHHHHHHHHHH
Confidence 99999999888888888887 24689999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhhhhhccccCC-cHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHH
Q 018141 239 ALVVVLALGFGHNIWAGFFSN-SPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAA 317 (360)
Q Consensus 239 ~~~~~~~~~~~~~~i~~l~~~-~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~ 317 (360)
+++.++++..+++++.++|++ |+|+.+.+.+++++.+++.++++.+....+.+||.||++.++..++.+ +++++|..+
T Consensus 325 ~~~~~~~~~~~~~~i~~lf~~~~~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~-~~v~ip~~~ 403 (453)
T PRK09575 325 GIAWVLLLNLFPETMIALFNSGDSELIAETIVGIRLHLFAMFLDGFLVLASAYFMAVNQGGKALFISIGN-MLIQLPFLF 403 (453)
T ss_pred HHHHHHHHHHhHHHHHHhHcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHHHHHHHh-HHHHHHHHH
Confidence 999999999999999999995 789999999999999999999999999999999999999999999887 578999999
Q ss_pred HHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 318 ILGFKLSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 318 ~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
++.. .+|+.|+|+++.+++.+..+...+++++
T Consensus 404 ll~~--~~G~~Gvw~a~~~~~~~~~~~~~~~~~~ 435 (453)
T PRK09575 404 ILPK--WLGVDGVWLAMPLSNIALSLVVAPMLWR 435 (453)
T ss_pred HHHH--HHCcchHhhHHHHHHHHHHHHHHHHHHH
Confidence 8854 3799999999999999988877666554
No 6
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=100.00 E-value=1.1e-42 Score=320.57 Aligned_cols=346 Identities=15% Similarity=0.112 Sum_probs=299.6
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
+++++.++++.++++.++++.++ ..+.++++.+++.|+|+.+.+.+|+++..++.|+..+....++.+|+.||++.+++
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 163 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVI 163 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHH
Confidence 46789999999999999988876 77889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhccccc-cccCCCCHHhHHhHHHHHHhHhHhHH
Q 018141 80 FSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFE-HTWEGFSFESFSFILTILKLALPSAA 158 (360)
Q Consensus 80 ~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~p~~~ 158 (360)
.++++.++|+++|+++++++++|+.|+++||.+++.+..++..++++++++.+ .+.+..+...++..|++++.|.|..+
T Consensus 164 ~~ii~~~vni~l~~~lI~~~~lGv~Gaa~At~is~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~ig~P~~~ 243 (441)
T PRK10367 164 LLVVGNILNIVLDLWLVMGLHMNVQGAALATVIAEYATLLIGLLMVRKVLKLRGISLEMLKTAWRGNFRRLLALNRDIML 243 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHcCCccHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHhhhhhHHHHHHHHHhCchHHH
Confidence 99999999999999999999999999999999999999888877775433222 11111121113578999999999999
Q ss_pred HHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHH
Q 018141 159 MVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLL 238 (360)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (360)
++......+.+.+.+++++| ++++|+|+++.++.++..++..|++++.+|.++|++|+||+|++|+..+++.+++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~G--~~alAa~~I~~~i~~~~~~~~~gl~~a~~~lvg~~~Ga~~~~~a~~~~~~~~~~~~~~ 321 (441)
T PRK10367 244 RSLLLQLCFGAITVLGARLG--SDIIAVNAVLMTLLTFTAYALDGFAYAVEAHSGQAYGARDGSQLLDVWRAACRQSGIV 321 (441)
T ss_pred HHHHHHHHHHHHHHHHHhcC--HHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHcCCCHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999998 7899999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhcc---chhHHHHHHHHHHHHHHHHH
Q 018141 239 ALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCG---WQHLAVWANLATFYFIGMPI 315 (360)
Q Consensus 239 ~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g---~~~~~~~~~~~~~~~~~i~~ 315 (360)
+.+.+++++.+++++.++|++|+|+.+.+.+++++.++..+.........+.++|.+ |++.++..++.+.|+..+
T Consensus 322 ~~~~~~~~~~~~~~i~~lFt~d~~v~~~~~~~l~i~~~~~~~~~~~~~~~~~~~g~lrg~dt~~~~~~~~~~~~~~~~-- 399 (441)
T PRK10367 322 ALLFSLVYALAGEHIIALLTSLPQIQQLADRYLIWQVILPLVGVWCYLLDGMFIGATRAAEMRNSMAVAAAGFALTLL-- 399 (441)
T ss_pred HHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhCccchHHHHHHHHHHHHHHHHHHH--
Confidence 999999999999999999999999999999999999876443334444444444444 599999999998764222
Q ss_pred HHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhccCchh
Q 018141 316 AAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRRKWTK 356 (360)
Q Consensus 316 ~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~~~~~ 356 (360)
. .+++|+.|+|++..+++.+.+++..+++++. |+|
T Consensus 400 ---~--~~~~g~~Gvw~a~~~~~~~~~i~~~~~~~~~-~~~ 434 (441)
T PRK10367 400 ---T--LPWLGNHGLWLALTVFLALRGLSLAAIWRRH-WRN 434 (441)
T ss_pred ---H--HHHcCchHHHHHHHHHHHHHHHHHHHHHHHH-Hhc
Confidence 2 2357999999999999999999887766554 865
No 7
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=100.00 E-value=2.2e-34 Score=272.17 Aligned_cols=340 Identities=15% Similarity=0.095 Sum_probs=291.5
Q ss_pred HHHHHHHHHHHHHHHHH-HHHH-HHhhHHHHHhc--CCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHH
Q 018141 3 GIYLQASWITSLFFSII-ISFL-WIYTEPILILL--HQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLI 78 (360)
Q Consensus 3 ~~~~~~~~~~~~~~~i~-~~~~-~~~~~~i~~~l--~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 78 (360)
++.+.++.+...+.+.+ ..++ +.+.+++..++ |.|++..+.+.+|+++..++.|+..+....++++|+++|++.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 157 (502)
T TIGR01695 78 RRAFANTVTTLLILSLLLVVLIGIFFAPFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPS 157 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHH
Confidence 44566666655544444 4444 77788888877 56788889999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCCCcchhH--HHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHh
Q 018141 79 FFSALPMAIHFGIAYAFVYLTSLGFKGAS--LAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPS 156 (360)
Q Consensus 79 ~~~~~~~~~~i~l~~~~i~~~~~g~~g~a--la~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~ 156 (360)
+.+++.++++++...++ ..++|..|++ +++++++.++.++.+++.++++. +. +++.+ .+++..|++++++.|.
T Consensus 158 ~~~i~~~i~~i~~~~~~--~~~~g~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~-~~-~~~~~-~~~~~~k~~l~~~~p~ 232 (502)
T TIGR01695 158 FSPILFNIGVILSLLFF--DWNYGQYSLALAIGVLIGGVAQLLIQLPFLRKAGF-LL-KPRFN-FRDPGLKRFLKLFLPT 232 (502)
T ss_pred HHHHHHHHHHHHHHHHH--HcccchHHHHHHHHHHHHHHHHHHHHHHHHHHCCC-cc-cCcCC-CCChhHHHHHHHHHHH
Confidence 99999998887754333 3478999988 99999999998888777654331 11 11122 2467899999999999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHH
Q 018141 157 AAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYM-ITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLS 235 (360)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~-~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 235 (360)
.+++...++...+|+.+.+.++ ++++++|+.+.++.++... +..+++++..|.+++++|+||+|+.|+..+++.+..
T Consensus 233 ~~~~~~~~~~~~id~~~~~~~~--~~~v~~~~~a~~l~~~~~~~~~~~i~~~~~P~~s~~~~~~~~~~~~~~~~~~~~~~ 310 (502)
T TIGR01695 233 TLGSSASQITLLINTALASFLE--IGSVSALYYANRIYQLPLGIFGISLSTVLLPKLSRHASEGNWNELRDLLNQGIRLS 310 (502)
T ss_pred HHHHHHHHHHHHHHHHHHhcCC--cchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHH
Confidence 9999999999999998877766 7789999999999988765 578999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhhccccCC----cHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHH
Q 018141 236 VLLALVVVLALGFGHNIWAGFFSN----SPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFI 311 (360)
Q Consensus 236 ~~~~~~~~~~~~~~~~~i~~l~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~ 311 (360)
..++.|.++++..+++++.+++.+ |+|..+.+..++++++++.++.+++..+.+.+++.||+|.+++.++.+. ++
T Consensus 311 ~~~~~~~~~~l~~~~~~ii~l~~~~~~f~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~a~g~~~~~~~~~~~~~-~i 389 (502)
T TIGR01695 311 LLLTIPSSFGLLILSIPIVSLLFERGAFSEEDTVMTATILAAYGLGLIFYSLQKVLLRAFYARKDTRTPFINSVISV-VL 389 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhccCCccCHHHHHHHH-HH
Confidence 999999999999999999999976 5677899999999999999999999999999999999999999999984 88
Q ss_pred HHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhcc
Q 018141 312 GMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 312 ~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~ 352 (360)
+++.++++ .+++|..|+|+++.+++.+..+...++.+|+
T Consensus 390 ~i~l~~~l--~~~~G~~G~~~a~~i~~~~~~~~~~~~~~~~ 428 (502)
T TIGR01695 390 NALLSLLL--IFPLGLVGIALATSAASMVSSVLLYLMLNRR 428 (502)
T ss_pred HHHHHHHH--HHHHhhhHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 99999988 4568999999999999999998887777665
No 8
>PRK15099 O-antigen translocase; Provisional
Probab=100.00 E-value=2e-31 Score=245.65 Aligned_cols=332 Identities=11% Similarity=0.001 Sum_probs=281.3
Q ss_pred hHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHH
Q 018141 2 LGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFF 80 (360)
Q Consensus 2 v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 80 (360)
.++++++++++.+..+++++++ +.+.+|+...++.+++. .++.++..+..+...+....++.+|+.+|++.++..
T Consensus 76 ~~~~~~~~~~l~~~~~~i~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~lr~~~~~~~~~~~ 151 (416)
T PRK15099 76 LRAVVGTSSAMVLGFSTLLALVFLLAAAPISQGLFGHTDY----QGVVRAVALIQMGIAWANLLLAILKGFRDAAGNALS 151 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChhH----HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 4678999999999999999887 88889999888766653 245666677777778889999999999999999999
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHhHHHH
Q 018141 81 SALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPSAAMV 160 (360)
Q Consensus 81 ~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~ 160 (360)
++.+.++|+.+ +++.+.. .|+.|+++|+++++.+..+...++++++++.+.+..+.+ .+++..|+++++|.|...++
T Consensus 152 ~~~~~~~~i~l-~i~~~~~-~Gv~Ga~iat~i~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~k~ll~~g~p~~~~~ 228 (416)
T PRK15099 152 LIVGSLIGVAA-YYLCYRL-GGYEGALLGLALVPALVVLPAGIMLIRRGTIPLSYLKPS-WDNGLAGQLGKFTLMALITS 228 (416)
T ss_pred HHHHHHHHHHH-HHHHHHH-hcchHHHHHHHHHHHHHHHHHHHHHHHccceehHhhhcc-CCHHHHHHHHHHHHHHHHHH
Confidence 99999999887 4444432 399999999999999998887777755443222221222 35788999999999999999
Q ss_pred HHHHHHHHHHHHHhc-CCCChhHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHH
Q 018141 161 CLEYWAFEILVFLAG-LMPNSELTTSLIAMCVNTESV-AYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLL 238 (360)
Q Consensus 161 ~~~~~~~~~~~~~~~-~~~~~~~~~a~~~~~~~i~~~-~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~ 238 (360)
....+....++.+++ ++| ++++|.|+.+.|+.+. ...+..+++++..|.++++ +|+|+.++..++..+....+
T Consensus 229 ~~~~i~~~~~~~~l~~~~g--~~~vg~y~~a~~i~~~~~~~~~~~~~~a~~P~~s~~---~~~~~~~~~~~~~~~~~~~~ 303 (416)
T PRK15099 229 VTLPVAYVMMRNLLAAHYS--WDEVGIWQGVSSISDAYLQFITASFSVYLLPTLSRL---TEKRDITREIVKALKFVLPA 303 (416)
T ss_pred HHHHHHHHHHHHHHHhcCC--HHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhc---CChHHHHHHHHHHHHHHHHH
Confidence 999999999999996 666 8899999999999774 5889999999999999995 67888999999999999999
Q ss_pred HHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHH
Q 018141 239 ALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAI 318 (360)
Q Consensus 239 ~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~ 318 (360)
+.+.+.++++++|++.+++.+|+ ++++.+++++++++.++...+......+.+.++++.....++.. .+++++++++
T Consensus 304 ~~~~~~~~~l~a~~ii~l~~g~~--~~~~~~~~~~l~~~~~l~~~~~~~g~~~~~~~~~~~~~~~~~~~-~~l~i~l~~~ 380 (416)
T PRK15099 304 VAAASFTVWLLRDFAIWLLFSNK--FTAMRDLFAWQLVGDVLKVGAYVFGYLVIAKASLRFYILAEVSQ-FTLLTGFAHW 380 (416)
T ss_pred HHHHHHHHHHHHHHHHHHhccHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHH
Confidence 99999999999999999999876 67788999999999999988888887788888888888888776 6889999999
Q ss_pred HHHHhCCCcceehHHHHHHHHHHHHHHHHHHh
Q 018141 319 LGFKLSLYVKGLWIGLICGLFCQASSLLLITL 350 (360)
Q Consensus 319 l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~ 350 (360)
+ .+.+|..|+++++.+++.+..+.......
T Consensus 381 l--i~~~G~~G~a~a~~is~~~~~~~~~~~~~ 410 (416)
T PRK15099 381 L--IPLHGALGAAQAYMATYIVYFSLCCGVFL 410 (416)
T ss_pred H--HHHhhhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 8 66789999999999999999987765554
No 9
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=100.00 E-value=1.2e-31 Score=252.67 Aligned_cols=343 Identities=16% Similarity=0.203 Sum_probs=284.6
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
++++.++++++++++.+++..++ ..+.+++...++.+++. ..++++..+..++..+....++.+|+++|++..+.
T Consensus 75 ~~~~~~~~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 150 (488)
T TIGR02900 75 NIKKILKVSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERS----LYSLLVICPAMPFIALSSVLKGYFQGISNMKPPAY 150 (488)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhH----HHHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHH
Confidence 35688899999999999998876 66777777766666543 34688899999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhh-----cCCCcchhHHHHHHHHHHHHHHHHHHHHhccccccc--cCCCCHHhHHhHHHHHHh
Q 018141 80 FSALPMAIHFGIAYAFVYL-----TSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHT--WEGFSFESFSFILTILKL 152 (360)
Q Consensus 80 ~~~~~~~~~i~l~~~~i~~-----~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~ 152 (360)
.+.++.++|+.++..++.. .+.|+.|+++++.+++.++.++.+.+.+++++.+.+ +.+..+.+++.+|+++++
T Consensus 151 ~~~i~~i~~~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~l~~~ 230 (488)
T TIGR02900 151 IQVIEQIVRISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRKKSFSIRFPFFDYKSEGKALLFDLFSV 230 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhcccccccCcchHHHHHHHHHH
Confidence 9999999998887766543 245678899999999999998877665443332222 111223457789999999
Q ss_pred HhHhHHHHHHHHHHHHHHHHHhcCCCC-----hhH---HHHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHH
Q 018141 153 ALPSAAMVCLEYWAFEILVFLAGLMPN-----SEL---TTSLI-AMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQ 223 (360)
Q Consensus 153 ~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~---~~a~~-~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~ 223 (360)
+.|.++++....+....|+.++++... ..+ ..+.| +.+.++..+...+..+++++..|.++++.|+||+|+
T Consensus 231 ~~p~~l~~~~~~~~~~~d~~ii~~~l~~~g~~~~~a~~~~g~~~~~a~~i~~~~~~~~~~l~~~~~p~~s~~~~~~~~~~ 310 (488)
T TIGR02900 231 SLPLTLSRFIGSLLYFLETLLVPQRLVIAGVTYREATSLYGKLSGMAMPLLTFPAVITSSLSTALVPDISEAMAKKNYSS 310 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHHHHHHHHHHHHChHHHHHHhHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 999999999999999999988875421 012 22333 355677777878889999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHH
Q 018141 224 AKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWA 303 (360)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 303 (360)
.++..+++.++...++.|..+++..++|++..++.++++ +.++++++++..++.+.+....+.+++.||+|.+++.
T Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ii~~~~~~~~----~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~ 386 (488)
T TIGR02900 311 IEKRINQAIKISLLLGLITTVILLVIPDELGALFYGRPD----AGNFIRVLAPSFPFLYFSAPLQSILQGLGKQKVALRN 386 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCc----hHHHHHHHHHHHHHHHHHHHHHHHHHhcCcchHHHHH
Confidence 999999999999999999999999999999999886543 6778999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhcc
Q 018141 304 NLATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 304 ~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~ 352 (360)
++.+. ++++++++.+...+++|+.|+++++.+++.+..+...+..+|.
T Consensus 387 ~~~~~-i~~i~l~~~l~~~~~~G~~Gaaia~~i~~~~~~~~~~~~~~~~ 434 (488)
T TIGR02900 387 SLIGA-IVKIILLFVLTSIPSINIYGYAITFIITSVLVTILNLAEIKKN 434 (488)
T ss_pred HHHHH-HHHHHHHHHHHhccccccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99985 8899999888544789999999999999999999888877654
No 10
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=100.00 E-value=5.5e-31 Score=236.90 Aligned_cols=272 Identities=29% Similarity=0.500 Sum_probs=247.1
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
+.++++++++.+..+.+++.+++ ..+.+|+..+++.|++..+.+.+|++++.+..++..+....++.+|+.+|++.++.
T Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 146 (342)
T TIGR00797 67 RLGRQAQQSLLLALLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMY 146 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHH
Confidence 35788999999999999999887 88889999998888899999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhh-hcC-CCcchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHhH
Q 018141 80 FSALPMAIHFGIAYAFVY-LTS-LGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPSA 157 (360)
Q Consensus 80 ~~~~~~~~~i~l~~~~i~-~~~-~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~ 157 (360)
.++++.++++.+++++++ .++ +|+.|+++++.+++.+..++.+++.+++++.+.++++..+.+++..|++++++.|.+
T Consensus 147 ~~i~~~~~~i~~~~~li~~~~g~~g~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~P~~ 226 (342)
T TIGR00797 147 ITLIGNVINIILNYILIFGKFGFLGIVGAALATVISYWLMFLLLLYYIKKAKKIGLKWEGLLKPDWEVLKRLLKLGLPIA 226 (342)
T ss_pred HHHHHHHHHHHHhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHHHHhCCCcccccccccCCCHHHHHHHHHhCchHH
Confidence 999999999999999887 567 889999999999999999988877765444333322223345788999999999999
Q ss_pred HHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHH
Q 018141 158 AMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVL 237 (360)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~ 237 (360)
+++....+...+++.+.++++ ++++++|+++.++.++...++.+++++..|.+++++|+||+++.++..+++.+....
T Consensus 227 ~~~l~~~~~~~~~~~i~~~~g--~~~v~~~~~a~~~~~~~~~~~~~~~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 304 (342)
T TIGR00797 227 FRVILESLSFALLALLVARLG--SIALAAHQIALNVESLLFMPAFGFGIAVSILVGQALGAGDPKRAKEVARVALKLSLL 304 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHcC--cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Confidence 999999999999999999987 889999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHH
Q 018141 238 LALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLL 274 (360)
Q Consensus 238 ~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~ 274 (360)
++++...++.++++++.++|++|+|+.+.+..++++.
T Consensus 305 ~~~~~~~~l~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 341 (342)
T TIGR00797 305 LGLVLAIILILFREFIARLFTNDPEVLELAAIYLIFV 341 (342)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHh
Confidence 9999999999999999999999999999999888764
No 11
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=100.00 E-value=1.2e-28 Score=227.68 Aligned_cols=340 Identities=16% Similarity=0.175 Sum_probs=297.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhc--CCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 3 GIYLQASWITSLFFSIIISFL-WIYTEPILILL--HQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 3 ~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l--~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
++..++.+....+.+++++++ .++++++.+.+ |.|++..+.+.++.+++.+..++..+..++.+++|+++|...+..
T Consensus 53 ~~f~~~~~~~~~~~~~~l~~l~~lfa~~iv~~la~g~~~~~~~la~~l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~ 132 (451)
T PF03023_consen 53 RRFISTLLTILLIISLLLTLLGILFAPPIVRLLAPGFSPETIELAVQLLRILAPSILFIGLSSIFSAILNAHRRFLIPAL 132 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHH
Confidence 566777777777777888776 88889998877 678899999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHhhhcCCC---cchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHh
Q 018141 80 FSALPMAIHFGIAYAFVYLTSLG---FKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPS 156 (360)
Q Consensus 80 ~~~~~~~~~i~l~~~~i~~~~~g---~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~ 156 (360)
.++..++..++...++. ...| +.+.++|..+|..++.++.+...+|.+.. .+ ++++. +.+..|++++...|.
T Consensus 133 ~~l~~N~~~I~~~~~~~--~~~~~~~i~~la~g~~~g~~~~~l~~l~~~~~~~~~-~~-~~~~~-~~~~~~~~~~~~~p~ 207 (451)
T PF03023_consen 133 SPLLFNLSIILSLLLLS--NSWGQENIYALAWGVLIGAIIQFLIQLPYLRRFGFR-FR-PKFDW-RDPNLKRFLKLAIPL 207 (451)
T ss_pred HHHHHHHHHHHHHHHHH--HhcCchHHHHHHHHHHHHHHHHHHHHHHHHHHCCCc-cc-ccCCC-CChhHHHHHHHHHHH
Confidence 98888877666543333 2456 88899999999999999988888644322 11 11121 245799999999999
Q ss_pred HHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHH
Q 018141 157 AAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAY-MITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLS 235 (360)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~-~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~ 235 (360)
.+.....++...+|+.+.+.++ +.++++++.+.++.++.. .+..+++++..|..++...+||.++.++..++.++..
T Consensus 208 ~l~~~~~qi~~lv~~~laS~l~--~G~vs~l~YA~~l~~lp~~i~~~~i~tv~~P~ls~~~~~~d~~~~~~~~~~~l~~~ 285 (451)
T PF03023_consen 208 LLSSSISQINILVDRALASFLG--EGSVSALNYAQRLYQLPLGIFAVSISTVVFPKLSRLAAEGDWEEFRKTLRKALRLI 285 (451)
T ss_pred HHHHHHHHHHHHHHHHHHhCCC--ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHH
Confidence 9999999999999999999988 779999999999999977 5577999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHhhhhhhccccCC----cHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHH
Q 018141 236 VLLALVVVLALGFGHNIWAGFFSN----SPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFI 311 (360)
Q Consensus 236 ~~~~~~~~~~~~~~~~~i~~l~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~ 311 (360)
..+.+|.++++..+++++++++.. |+|..+..++.+++++++.++.+++..+...+.+.||+|.++..++.+ .++
T Consensus 286 ~~i~iP~~~~~~~~a~~iV~llf~rG~F~~~~~~~ta~~l~~y~~~l~~~~l~~ll~r~fya~~~~~~~~~~~~~~-~~l 364 (451)
T PF03023_consen 286 LLILIPASIGLIVLAEPIVRLLFERGAFTAEDTQLTASALRIYALGLPFYALNDLLSRVFYALGDTKTPVRISVIS-VVL 364 (451)
T ss_pred HHHHHHHHHHHHHhhHHHHHHHHccCCCCHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHccCcHhHHHHHHHH-HHH
Confidence 999999999999999999999852 567789999999999999999999999999999999999999999999 589
Q ss_pred HHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhcc
Q 018141 312 GMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 312 ~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~ 352 (360)
++.+++.+ .+.+|..|.++++.++..+.++...+..+|+
T Consensus 365 ni~l~~~l--~~~~g~~Glala~sl~~~i~~~~l~~~l~r~ 403 (451)
T PF03023_consen 365 NIILSILL--VPFFGVAGLALATSLSAIISALLLYILLRRR 403 (451)
T ss_pred HHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999888 6678999999999999999999888877766
No 12
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.97 E-value=2.4e-30 Score=237.03 Aligned_cols=356 Identities=42% Similarity=0.706 Sum_probs=337.6
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFLWIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFF 80 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 80 (360)
+++.+.+++..+....+++.+.++...+|++..+++|+++...+..|.++..+..+......-.+.++|++++..+..+.
T Consensus 103 ~lg~~lqrs~~~l~~~~~~~~~l~~~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~~~ 182 (473)
T KOG1347|consen 103 ALGVYLQRSGIVLLVQGLPISLLILNSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLLVI 182 (473)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHHHH
Confidence 36789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHhHHHH
Q 018141 81 SALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPSAAMV 160 (360)
Q Consensus 81 ~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~ 160 (360)
.....++|+.+++++++.+++|..|++++..++++........+....+ ....|..+..+ ++.++++++.+.|.+++.
T Consensus 183 ~~~~~~lhi~~~~llv~~~~~g~~Gaala~~~s~w~~~~~l~~yi~~~~-~~~~w~~~s~~-~~~~~~~~~lai~s~~mi 260 (473)
T KOG1347|consen 183 GLVALVLHILLTWLLVSKLGLGIKGAALALVASYWLNVRILLLYAVLSG-CLAAWSGFSGE-FDSWGPFFALAIPSAVMI 260 (473)
T ss_pred HHHHHHHHHHHHHHhhhcccCCCccchHHHHHHHHHHHHHHHHHheecC-chhhhhhhhHh-hhhHHHHHHHhhcchhee
Confidence 9999999999999999999999999999999999999999988886555 45566666666 899999999999999999
Q ss_pred HHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH
Q 018141 161 CLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLAL 240 (360)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (360)
..+.+.+.......|..++++.++++.++..++.....+++.+++.+...++++.+|+++++++|...+.....+...+.
T Consensus 261 clE~w~~eil~l~~G~l~np~~~~~~~sI~~~~~~~~~~~~~~~~~a~strv~neLGag~p~~ar~~~~v~~~~~~~~g~ 340 (473)
T KOG1347|consen 261 CLEWWAYEILVLLAGLLGNAKVSLASQSICLEIGGWHLMIPGAFSAAVSTRVSNELGAGKPKRARVSAKVALQTSVAIGA 340 (473)
T ss_pred HHHHHHHHHHHHHHhccCCcHHHHHHHHHHHHHHHHHHHHhhhhhhhHHHHHHHHHcCCChhhhhhHHHHHHHHHHHHHH
Confidence 99999999999999999987899999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHH
Q 018141 241 VVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAILG 320 (360)
Q Consensus 241 ~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~ 320 (360)
..+..+....+.+..+|++|+|+.+...+..++++...++++.+.++.+..+|.|+++...+.++....++++|....+.
T Consensus 341 ~~~~~~~~~r~~~~~ift~~~ev~~~va~~~pll~~~~~~~~~q~v~~Gva~g~g~q~~ga~vnl~~yyl~G~p~g~~l~ 420 (473)
T KOG1347|consen 341 SLGTTLLACREVLGQIFTNSKEVLDLVADLTPLLALSILLNALQAVLSGVARGSGWQQIGAVINLVAYYLVGAPVGLYLG 420 (473)
T ss_pred HHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHHHHHHHHhccchhhhhheEEeeccccceEEEeeeeeeEecCcceeEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred HHhCCCcceehHHHHHHHHHHHHHHHHHHhccCchhhh
Q 018141 321 FKLSLYVKGLWIGLICGLFCQASSLLLITLRRKWTKVD 358 (360)
Q Consensus 321 ~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~~~~~~~ 358 (360)
+..++|..|.|.+...+..+..........+.+|+++.
T Consensus 421 ~~~~~g~~glw~G~~~~~~~~~~~l~~~~~~tdW~~~~ 458 (473)
T KOG1347|consen 421 FFTKFGVKGLWIGILLGFSVQTLVLAIVTARTDWKNQA 458 (473)
T ss_pred EEEecCceEEEeehHHHHHHHHHHHHHheeeccHHHHH
Confidence 77899999999999999888888888888889999854
No 13
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.96 E-value=1.3e-24 Score=198.02 Aligned_cols=337 Identities=15% Similarity=0.090 Sum_probs=282.9
Q ss_pred HHHHHHHHHHHHHHH-HHhhHHHHHhcCC---ChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHHHHHH
Q 018141 9 SWITSLFFSIIISFL-WIYTEPILILLHQ---DPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFFSALP 84 (360)
Q Consensus 9 ~~~~~~~~~i~~~~~-~~~~~~i~~~l~~---~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 84 (360)
.......+.++++++ .++.+.+.+.+.. |++....+....+++.|.+++..+.....+.+|+.+|...+++.++..
T Consensus 93 v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~F~~~a~aPvl~ 172 (518)
T COG0728 93 VTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNRFFIPAFAPVLL 172 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeechhhhhHHHH
Confidence 333666666666766 6666666645522 344444678888999999999999999999999999999999999988
Q ss_pred HHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHhHHHHHHHH
Q 018141 85 MAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPSAAMVCLEY 164 (360)
Q Consensus 85 ~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~ 164 (360)
++.-+.....+......-..+.++|..++.+.+.++.+..++|.+...+. ++. .+.+..|++.+.-.|..+.....+
T Consensus 173 Nv~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~g~~~~p--~~~-~~~~~lk~~~~~~~p~~l~~sisQ 249 (518)
T COG0728 173 NVSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKAGLLIKP--RFG-FKDPGLKRFLKLMLPALLGVSISQ 249 (518)
T ss_pred HHHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHcccccCC--CCC-CCchhHHHHHHHHHHHHHHHHHHH
Confidence 88887555444433222366889999999999999999999755422111 111 123689999999999999999999
Q ss_pred HHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHHHH
Q 018141 165 WAFEILVFLAGLMPNSELTTSLIAMCVNTESVAY-MITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLALVVV 243 (360)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~-~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (360)
+...+|+.+.+... +.+++.+..++++.++.. .+..+++++..|..|++..++|.++.++..+.+++.+..+++|.+
T Consensus 250 i~lli~~~iAS~l~--~Gsis~l~YA~rl~qlPlGifgvai~tvllP~lSr~~~~~~~~~~~~~l~~~i~l~lll~lP~~ 327 (518)
T COG0728 250 INLLIDTAIASFLA--EGSVSWLYYADRLYQLPLGIFGVALSTVLLPSLSRHAANGDWPEFLKLLDWGLRLTLLLTLPAS 327 (518)
T ss_pred HHHHHHHHHHHhhc--cccHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHhhcCChHHHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999987 678999999999999977 678899999999999999999999999999999999999999999
Q ss_pred HHHHhhhhhhccccCC----cHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHH
Q 018141 244 LALGFGHNIWAGFFSN----SPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAIL 319 (360)
Q Consensus 244 ~~~~~~~~~i~~l~~~----~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l 319 (360)
+++..+++|+.+.+.. +++.....++.+..++.+.++..+..++...+++.+|+|.|+++++++ .++|+.+++.+
T Consensus 328 ~~l~~la~piv~~Lf~rG~F~~~d~~~ta~~L~~y~~gL~~~~L~~ll~~~FYAr~d~ktP~~i~ii~-~~~n~~l~~~l 406 (518)
T COG0728 328 AGLLVLAEPIVSLLFERGAFTAEDVLMTAEALAAYSLGLIPFALVKLLSRVFYAREDTKTPMKIAIIS-LVVNILLNLLL 406 (518)
T ss_pred HHHHHHHHHHHHHHhccCCCChHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHccCCCcChHHHHHH-HHHHHHHHHHH
Confidence 9999999999999843 456678899999999999999999999999999999999999999999 58999999776
Q ss_pred HHHhCCCcceehHHHHHHHHHHHHHHHHHHhccC
Q 018141 320 GFKLSLYVKGLWIGLICGLFCQASSLLLITLRRK 353 (360)
Q Consensus 320 ~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~~ 353 (360)
.+.+|..|.+.++.++.++++.+.++..+|+.
T Consensus 407 --~~~~~~~giala~s~a~~~~~~ll~~~l~k~~ 438 (518)
T COG0728 407 --IPPLGHVGLALATSLAAWVNALLLYYLLRKRL 438 (518)
T ss_pred --HhhccchHHHHHHHHHHHHHHHHHHHHHHHhc
Confidence 66689999999999999888888777766653
No 14
>PRK10459 colanic acid exporter; Provisional
Probab=99.95 E-value=1.8e-24 Score=203.90 Aligned_cols=329 Identities=14% Similarity=0.113 Sum_probs=271.3
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHHH
Q 018141 3 GIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFFS 81 (360)
Q Consensus 3 ~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 81 (360)
++..++.+++....+++..++ +.+.+++...++.| +. ...+++..+..++..+....++.+|.+++++.....+
T Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~ 148 (492)
T PRK10459 74 HLQLSTLYWLNVGLGIVVFVLVFLLSPLIADFYHNP-EL----APLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIE 148 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCh-hh----HHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHH
Confidence 456778888888888888776 55566666555543 32 3457788888888888899999999999999999999
Q ss_pred HHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHhHHHHH
Q 018141 82 ALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPSAAMVC 161 (360)
Q Consensus 82 ~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~ 161 (360)
....++..++...+.+ .+.|..+.++++++++.+..+....... + +.+++ . +.+++..|++++++.|...++.
T Consensus 149 ~~~~i~~~~~~i~~~~-~~~g~~~l~~~~~~~~~~~~l~~~~~~~-~-~~~~~---~-~~~~~~~k~ll~~~~~~~~~~~ 221 (492)
T PRK10459 149 ISAVVAGFTFAVVSAF-FWPGALAAILGYLVNSSVRTLLFGYFGR-K-IYRPA---L-HFSLASVKPNLSFGAWQTAERI 221 (492)
T ss_pred HHHHHHHHHHHHHHHH-HCCcHHHHHHHHHHHHHHHHHHHHHHhc-c-cCCcc---c-eecHHHHHHHHhhhHHHHHHHH
Confidence 9988888877766655 3789999999999999887765443332 2 11111 1 1246778999999999999999
Q ss_pred HHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHH
Q 018141 162 LEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAY-MITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLAL 240 (360)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~-~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~ 240 (360)
...+....|+.+++++. |++++|.|+.+.++.+... .+...++++..|..++. ++|+++.++..++..+....+++
T Consensus 222 ~~~~~~~~d~~~lg~~l-g~~~vG~Y~~A~~l~~~~~~~i~~~i~~v~~P~~s~~--~~~~~~~~~~~~~~~~~~~~~~~ 298 (492)
T PRK10459 222 INYLNTNIDTILIGRIL-GAEVLGGYNLAYNVATVPPMKINPIITRVAFPVFAKI--QDDTEKLRVGFLKLLSVLGIINF 298 (492)
T ss_pred HHHHHhcCchhhhhHhh-chHhhhhHHHHHHHHHHHHHHHHHHHHHHHhHHHHHh--cCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999886 5889999999999988754 45556888999999885 67889999999999999999999
Q ss_pred HHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHH
Q 018141 241 VVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAILG 320 (360)
Q Consensus 241 ~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~ 320 (360)
|..+++.++++++..++.+|+ ++++...++++++...+..........+++.||+|..+..++... ++.+|..+.+
T Consensus 299 p~~~~l~~~a~~ii~ll~g~~--~~~a~~~l~il~~~~~~~~~~~~~~~~l~a~g~~~~~~~~~~~~~-~~~i~~~~~~- 374 (492)
T PRK10459 299 PLLLGLMVVSNNFVPLVFGEK--WNSAIPILQLLCIVGLLRSVGNPIGSLLLAKGRADLSFKWNVFKT-FLFIPAIVIG- 374 (492)
T ss_pred HHHHHHHHHhHHHHHHhcChh--HHhHHHHHHHHHHHHHHHHHHHHHHHHHHHcCccchhHHHHHHHH-HHHHHHHHHH-
Confidence 999999999999999888765 788999999999999999999999999999999999999999884 7788887766
Q ss_pred HHhCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 321 FKLSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 321 ~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
.+.+|+.|+++++.+++.+......++.+|
T Consensus 375 -~~~~G~~g~a~a~~i~~~~~~~~~~~~~~~ 404 (492)
T PRK10459 375 -GQLAGLIGVALGFLLVQIINTILSYFLMIK 404 (492)
T ss_pred -HhhccHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 456799999999999999998887776634
No 15
>COG0534 NorM Na+-driven multidrug efflux pump [Defense mechanisms]
Probab=99.95 E-value=2.2e-25 Score=205.91 Aligned_cols=209 Identities=22% Similarity=0.272 Sum_probs=200.7
Q ss_pred hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCCh
Q 018141 142 SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNP 221 (360)
Q Consensus 142 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~ 221 (360)
.++..|+++++++|.+++++.......+|++++|+++ ++++|+.++++++..+...+..+++.+..+.++|++|+||+
T Consensus 12 ~~~~~k~l~~la~P~i~~~l~~~l~~~vD~~~vG~~~--~~alaav~la~~i~~~~~~~~~gl~~g~~~liaq~~Ga~~~ 89 (455)
T COG0534 12 FKKILKLLLKLAIPIILGNLLQTLYGLVDTFMVGHLG--AEALAAVGLANPIFFLIIAIFIGLGTGTTVLVAQAIGAGDR 89 (455)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccc--HHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHcCCch
Confidence 4679999999999999999999999999999999998 89999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHH
Q 018141 222 DQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAV 301 (360)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 301 (360)
+++++..+++...+.+++++..++...+++++.+++++++|+.+.+.+|+++..++.++..++..+.+.+|+.||+|.++
T Consensus 90 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ll~~l~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~m 169 (455)
T COG0534 90 KKAKRVLGQGLLLALLLGLLLAILLLFFAEPLLRLLGAPAEVLELAAEYLRIILLGAPFALLSFVLSGILRGLGDTKTPM 169 (455)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCCHhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCchhH
Confidence 99999999999999999999999999999999999999888999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-hC-CCcceehHHHHHHHHHHHHHHHHHHhccC
Q 018141 302 WANLATFYFIGMPIAAILGFK-LS-LYVKGLWIGLICGLFCQASSLLLITLRRK 353 (360)
Q Consensus 302 ~~~~~~~~~~~i~~~~~l~~~-~~-~g~~G~~~a~~~~~~~~~i~~~~~~~~~~ 353 (360)
+.++.+. +.|+.+++++.+. .+ +|+.|+++|+.+++.+.++...++.+|++
T Consensus 170 ~~~~~~~-~lNivln~llI~g~~g~lGv~GAA~AT~ia~~~~~~~~~~~~~~~~ 222 (455)
T COG0534 170 YILLLGN-LLNIVLNYLLIFGLFGGLGVAGAALATVIARWIGALLLLIYLLRKK 222 (455)
T ss_pred HHHHHHH-HHHHHhhHHHHHhccccccchhHHHHHHHHHHHHHHHHHHHHHhcc
Confidence 9999995 9999999999887 46 99999999999999999999888877765
No 16
>PRK00187 multidrug efflux protein NorA; Provisional
Probab=99.94 E-value=5.5e-25 Score=204.89 Aligned_cols=206 Identities=20% Similarity=0.105 Sum_probs=190.3
Q ss_pred hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCCh
Q 018141 142 SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNP 221 (360)
Q Consensus 142 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~ 221 (360)
++++.|++++.++|.+++++...+....|+.++++++ ++++++++++.++..+...+..+++++..+.++|++|+||+
T Consensus 5 ~~~~~k~il~~a~P~~~~~~~~~~~~~~d~~~v~~lg--~~alAa~~i~~~i~~~~~~~~~gl~~~~~~i~aq~~Ga~~~ 82 (464)
T PRK00187 5 PTTELKAILRLAGPLIASQLAHMLMVFTDTLMMGRLG--PEALAGGGLGAASYSFVSIFCVGVIAAVGTLVAIRHGAGDI 82 (464)
T ss_pred cHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccC--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCh
Confidence 5778999999999999999999999999999999998 88999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHH
Q 018141 222 DQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAV 301 (360)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 301 (360)
|++++..+++..+..+++++..+++. +.+++.++++.|+|+.+.+.+|+++.+++.++..+....++++|+.||++.++
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~il~l~~~~~ev~~~~~~Yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~~ 161 (464)
T PRK00187 83 EGATRLAQAGLWLAWLLALVAALLLW-NLKPLLLLFGQAPQNVDAAMQFLHLLPFALPGYLSFMALRGFTSALGRAGPVM 161 (464)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCcHHHH
Confidence 99999999999999999998877665 67999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHH----hCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 302 WANLATFYFIGMPIAAILGFK----LSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 302 ~~~~~~~~~~~i~~~~~l~~~----~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
+.++.+. +++++++|.+.+. |++|+.|+++|+.+++....+...+++++
T Consensus 162 ~~~~~~~-~~ni~~~~~lIfg~~g~p~~Gv~Gaalat~i~~~~~~~~~~~~~~~ 214 (464)
T PRK00187 162 VISLAGA-VANLLLNYALIEGWFGLPKLGLMGIGLVTALVSNGMALALALYIRR 214 (464)
T ss_pred HHHHHHH-HHHHHHHHHHHcCCCCCccccccchHHHHHHHHHHHHHHHHHHHHh
Confidence 9999994 8899999998653 35899999999999988877765555543
No 17
>PRK10367 DNA-damage-inducible SOS response protein; Provisional
Probab=99.94 E-value=5.1e-25 Score=203.41 Aligned_cols=207 Identities=15% Similarity=0.111 Sum_probs=194.3
Q ss_pred HHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChH
Q 018141 143 FSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPD 222 (360)
Q Consensus 143 ~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~ 222 (360)
+++.|++++.++|.++++....+...+|+.++|+++ ++.++|+.+++.++..+...+..+++.+..+.++|++|+||+|
T Consensus 5 ~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~l~-g~~alAa~~l~~~i~~~~~~~~~~~~~g~~~lvsq~~Ga~~~~ 83 (441)
T PRK10367 5 TSSDKALWRLALPMIFSNITVPLLGLVDTAVIGHLD-SPVYLGGVAVGATATSFLFMLLLFLRMSTTGLTAQAFGAKNPQ 83 (441)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCHH
Confidence 567899999999999999999999999999999985 3778999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHH
Q 018141 223 QAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVW 302 (360)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 302 (360)
++++..++++..+.+.+++...+...+.+++.++++.|+|+.+.+.+|+++..++.++..+.....+.+|+.||+|.+++
T Consensus 84 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ll~~~g~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~~~ 163 (441)
T PRK10367 84 ALARALVQPLLLALGAGALIALLRTPLIDLALHIVGGSEAVLEQARRFLEIRWLSAPASLANLVLLGWLLGVQYARAPVI 163 (441)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccchHHHH
Confidence 99999999999999999999888888999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 303 ANLATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 303 ~~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
.++++. ++|+++++++.+.+++|+.|+++|+.+++.+..+...++++|
T Consensus 164 ~~ii~~-~vni~l~~~lI~~~~lGv~Gaa~At~is~~~~~i~~~~~~~~ 211 (441)
T PRK10367 164 LLVVGN-ILNIVLDLWLVMGLHMNVQGAALATVIAEYATLLIGLLMVRK 211 (441)
T ss_pred HHHHHH-HHHHHHHHHHHHHcCCccHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999995 889999999988888999999999999999988876555543
No 18
>PRK10189 MATE family multidrug exporter; Provisional
Probab=99.94 E-value=8.9e-25 Score=203.67 Aligned_cols=205 Identities=17% Similarity=0.193 Sum_probs=192.2
Q ss_pred HHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChH
Q 018141 143 FSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPD 222 (360)
Q Consensus 143 ~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~ 222 (360)
-+..|++++.++|.++++........+|+.+++++| ++++|++++++++..+...+..+++++..+.++|++|+||+|
T Consensus 25 ~~~~k~il~la~P~~~~~~~~~~~~~vd~~~vg~lG--~~alAA~~i~~~i~~~~~~~~~gl~~g~~~lvsq~~Ga~~~~ 102 (478)
T PRK10189 25 VLFWREITPLAVPIFIENLCVLLMGVLSTFLVSWLG--KEAMAGVGLADSFNMVIMAFFAAIDLGTTVVVAFSLGKRDRR 102 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCHH
Confidence 345999999999999999999999999999999998 899999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccC--CcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHH
Q 018141 223 QAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFS--NSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLA 300 (360)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~--~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 300 (360)
++++..+++..++..++++.+.+.+.+++++.+++. .|+|+.+.+.+|+++..++.++..++....+.+|+.||++.+
T Consensus 103 ~~~~~~~~~l~~~~~~~~~~~~l~~~~~~~ll~l~~~~~~~~v~~~a~~Yl~i~~~~~~~~~~~~~~~~~lr~~G~~~~~ 182 (478)
T PRK10189 103 RARAAARQSLVIMTLFAVLLAVLIHFFGEQIIDLVAGDATPEVKALALTYLELTVWSYPAAAITLIGSGALRGAGNTKIP 182 (478)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHhCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCchHHh
Confidence 999999999999999999999999999999999995 689999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH----hCCCcceehHHHHHHHHHHHHHHHHHHh
Q 018141 301 VWANLATFYFIGMPIAAILGFK----LSLYVKGLWIGLICGLFCQASSLLLITL 350 (360)
Q Consensus 301 ~~~~~~~~~~~~i~~~~~l~~~----~~~g~~G~~~a~~~~~~~~~i~~~~~~~ 350 (360)
+..++.+ +++|+++++.+.+. +++|+.|+|+|+.+++.+..+...+++.
T Consensus 183 ~~i~~~~-~~~ni~l~~~li~g~~~~~~lGv~Gaa~At~is~~~~~~~~~~~~~ 235 (478)
T PRK10189 183 LLINGGM-NILNIIISSILIYGLFSWQGLGFVGAGLGLTISRYIGAVAIIWVLM 235 (478)
T ss_pred HHHHHHH-HHHHHHHhHHHHhcCCCCCccchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999997 58999999998764 4799999999999999998887655544
No 19
>PRK09575 vmrA multidrug efflux pump VmrA; Reviewed
Probab=99.94 E-value=1.3e-24 Score=202.08 Aligned_cols=208 Identities=14% Similarity=0.026 Sum_probs=196.5
Q ss_pred hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 018141 142 SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLM-PNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGN 220 (360)
Q Consensus 142 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~ 220 (360)
+++..|++++.++|.++++....+...+|+.+++++ + ++++++++++.++.++...+..+++.+..+.++|++|+||
T Consensus 7 ~~~~~k~i~~l~~P~~~~~l~~~l~~~~d~~~lg~~~g--~~~laa~~~~~~~~~~~~~~~~~~~~g~~~lvsq~~Ga~~ 84 (453)
T PRK09575 7 NQSIYRTFWRYTIPSIAAMLVNGLYQIVDGIFIGHYVG--AEGLAGINMAWPVIGIILGIGLMVGMGTGSLLSIKRGEGD 84 (453)
T ss_pred cCchHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccccc--HHHHHHHHHHHHHHHHHHHHHHHHhccHHHHHHHHhcCCC
Confidence 466889999999999999999999999999999997 6 8899999999999999999999999999999999999999
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHH
Q 018141 221 PDQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLA 300 (360)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~ 300 (360)
+|++++..+++++++.+++++.+++...+++++.++++.|+|+.+.+.+|+++.+++.++..+.....+.+|+.||++.+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~il~l~~~~~~~~~~~~~yl~i~~~~~~~~~l~~~~~~~l~~~g~~~~~ 164 (453)
T PRK09575 85 LEKAKRILTTGLLLLLLLGPIVSVILFLFADDFLRAQGAEGRTLELALQYIQVLIWGCLFTLGAIALPFLLRNDESPNLA 164 (453)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhcc
Q 018141 301 VWANLATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 301 ~~~~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~ 352 (360)
+..++.+ .++++++++++.+.+++|+.|+++|+.+++.+..+...++++++
T Consensus 165 ~~~~~~~-~~~ni~l~~~li~~~~~Gi~Gaa~At~is~~~~~~~~~~~~~~~ 215 (453)
T PRK09575 165 TGLMVIG-ALINIVLDYLFIGWLDWGLTGAAIATALAQLVVTVLGLGYFFSS 215 (453)
T ss_pred HHHHHHH-HHHHHHhhHHHHHhCCchhHHHHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999 58999999999887889999999999999999998876666543
No 20
>PRK01766 multidrug efflux protein; Reviewed
Probab=99.93 E-value=1.7e-23 Score=195.30 Aligned_cols=209 Identities=17% Similarity=0.133 Sum_probs=194.9
Q ss_pred hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCCh
Q 018141 142 SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNP 221 (360)
Q Consensus 142 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~ 221 (360)
.++.+|+++++++|.++++....+...+|+.++++++ ++++++++++.++..+...+..+++.+..|.++|++|+||+
T Consensus 7 ~~~~~~~il~~~~P~~~~~~~~~~~~~~d~~~i~~~g--~~~laa~~~~~~~~~~~~~~~~g~~~a~~~~vs~~~g~~~~ 84 (456)
T PRK01766 7 YKSEARQLLALALPILLAQVAQTAMGFVDTVMAGGVS--ATDLAAVAIGTSIWLPVILFGHGLLLALTPIVAQLNGAGRR 84 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccC--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCh
Confidence 4778999999999999999999999999999999987 88999999999998888889999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHH
Q 018141 222 DQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAV 301 (360)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 301 (360)
|+.++..+++..++..++++.+++++.+++++.++++.|+|+.+.+.+++++.+++.++..+.....+++|+.||++.++
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~yl~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 164 (456)
T PRK01766 85 ERIAHQVRQGLWLALFLSVLIMLVLYNAVPPILNMMNLEPEVADIAVGYLHALLWGIPAYLLYQVLRSFIDGLGKTKPTM 164 (456)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCCChHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHH----hCCCcceehHHHHHHHHHHHHHHHHHHhccC
Q 018141 302 WANLATFYFIGMPIAAILGFK----LSLYVKGLWIGLICGLFCQASSLLLITLRRK 353 (360)
Q Consensus 302 ~~~~~~~~~~~i~~~~~l~~~----~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~~ 353 (360)
+.++++. ++++++++.+.+. +++|+.|+++++.+++.+..+...++.+|++
T Consensus 165 ~~~~i~~-ivni~l~~~li~~~~~~~~~Gv~Gaa~at~is~~~~~~~~~~~~~~~~ 219 (456)
T PRK01766 165 VIGFLGL-LINIPLNYIFIYGKFGFPELGGVGCGVATAIVYWVMFLAMLIYIKRAR 219 (456)
T ss_pred HHHHHHH-HHHHHHHHHHHcCCCCCcccccccHHHHHHHHHHHHHHHHHHHHHhCh
Confidence 9999985 8899999988643 5689999999999999999988777666543
No 21
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=99.90 E-value=2.8e-20 Score=175.06 Aligned_cols=278 Identities=17% Similarity=0.170 Sum_probs=232.0
Q ss_pred HHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHH
Q 018141 46 LYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFFSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYV 125 (360)
Q Consensus 46 ~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~ 125 (360)
...++..+..+........++.+|+.++++..... ......-......+. ........++...+......+...+.
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (480)
T COG2244 118 LLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALS-IVSSIFLLAAVFALL---FAALGLAVWALVLGAVVSLLVLLILL 193 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhH-HHHHHHHHHHHHHHH---HHhhhHHHHHHHHHHHHHHHHHHHHH
Confidence 34778899999999999999999999999999988 444311112211112 13445667777777777766666555
Q ss_pred HhccccccccCCCCHHhHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHH
Q 018141 126 LCAKKFEHTWEGFSFESFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLS 205 (360)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~ 205 (360)
.++++...+ ... +..++..|+.++++.|....+....+....|+++++++. +++++|.|+.+.++......+..+++
T Consensus 194 ~~~~~~~~~-~~~-~~~~~~~~~~l~~~~p~~~~~~~~~l~~~~D~~~i~~~l-~~~~vG~Y~~a~~i~~~~~~~~~~l~ 270 (480)
T COG2244 194 GKKKRGLKR-PIL-RFSLALLKELLRFGLPLLLSSLLNFLFTNIDTLLLGLFL-GPAQVGIYSAAQRLVSLLLIVASALN 270 (480)
T ss_pred HHhhhhccc-ccc-CchhHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHh-hhhHheecccccHHHHHHHHHHHHHH
Confidence 422221111 111 114789999999999999999999999999999999987 58999999999999999999999999
Q ss_pred HHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHH
Q 018141 206 AAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQG 285 (360)
Q Consensus 206 ~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~ 285 (360)
.+..|..++..+++|.++.++..+++.++...++.|..+++..+++++..++.+++ ++.+...++++++..++.+...
T Consensus 271 ~~l~P~~s~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~l~~~~~~~i~~~fg~~--~~~~~~~l~il~~~~~~~~~~~ 348 (480)
T COG2244 271 RVLFPALSRAYAEGDRKALKKLLRQSLKLLLLISIPALLGLLLLAPPIITLLFGEK--YASAAPILQLLALAGLFLSLVS 348 (480)
T ss_pred HHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhhheeecCCc--ccchhHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999998776 5558999999999999999999
Q ss_pred HHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhCCCcceehHHHH
Q 018141 286 VLSGVARGCGWQHLAVWANLATFYFIGMPIAAILGFKLSLYVKGLWIGLI 335 (360)
Q Consensus 286 ~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~ 335 (360)
.....+++.|+++..++.+..+. +.++.+++.+ ++++|..|++.++.
T Consensus 349 ~~~~~l~~~g~~~~~~~~~~~~~-i~~~~l~~~l--i~~~g~~g~~~a~~ 395 (480)
T COG2244 349 LTSSLLQALGKQRLLLLISLISA-LLNLILNLLL--IPRFGLIGAAIATA 395 (480)
T ss_pred HHHHHHHHcCcchhhHHHHHHHH-HHHHHHHhHH--HHhhhhhhHHHHHH
Confidence 99999999999999999999994 8899999988 77789999999993
No 22
>TIGR00797 matE putative efflux protein, MATE family. The MATE family consists of probable efflux proteins including a functionally characterized multi drug efflux system from Vibrio parahaemolyticus, a putative ethionine resistance protein of Saccharomyces cerevisiae, and the functionally uncharacterized DNA damage-inducible protein F (DinF) of E. coli. These proteins have 12 probable TMS.
Probab=99.87 E-value=9.8e-20 Score=163.82 Aligned_cols=194 Identities=20% Similarity=0.214 Sum_probs=180.4
Q ss_pred HhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHH
Q 018141 155 PSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKL 234 (360)
Q Consensus 155 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~ 234 (360)
|.+++++...+....|+.++++++ ++++++++.+.++..+...+..+++++..|.++++.|++|+|+.++..++....
T Consensus 1 p~~~~~~~~~~~~~~~~~~~~~~g--~~~~~~~~~a~~i~~~~~~~~~~i~~~~~~~~s~~~g~~~~~~~~~~~~~~~~~ 78 (342)
T TIGR00797 1 PAILANILQPLLGLVDTAFVGHLG--PVDLAAVSLGSSVFMFLFSILMGLGTATTALVAQAVGAGNYQRLGRQAQQSLLL 78 (342)
T ss_pred ChHHHHHHHHHHHHHHHHHHhccc--HHHHHHHHHhHHHHHHHHHHHHHHHHhHHHHHHHHHCCCChHHHHHHHHHHHHH
Confidence 788999999999999999999988 889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHH
Q 018141 235 SVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMP 314 (360)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~ 314 (360)
..+++++.+++..++++++.++++.|++..+++.++++++++..++.+.+....+.+++.||.+.+.+.++.+. +++++
T Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~~~-~~~i~ 157 (342)
T TIGR00797 79 ALLLGLPVLLVGYFFIDPLLSLMGADGEVAELAQDYLRILILGIPAYLLNFVLRGFLRGQGDTKTPMYITLIGN-VINII 157 (342)
T ss_pred HHHHHHHHHHHHHHhHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCchHHHHHHHHHH-HHHHH
Confidence 99999999999999999999999878888999999999999999999999999999999999999999999985 88888
Q ss_pred HHHHHHH-HhC-CCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 315 IAAILGF-KLS-LYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 315 ~~~~l~~-~~~-~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
.++.+.. ..+ +|+.|+++++.+++.+..+...++.+|
T Consensus 158 ~~~~li~~~~g~~g~~g~~~~~~~~~~~~~~~~~~~~~~ 196 (342)
T TIGR00797 158 LNYILIFGKFGFLGIVGAALATVISYWLMFLLLLYYIKK 196 (342)
T ss_pred HhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 8888865 445 779999999999999998887766664
No 23
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=99.85 E-value=2.3e-21 Score=155.14 Aligned_cols=162 Identities=25% Similarity=0.439 Sum_probs=158.0
Q ss_pred HhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHH
Q 018141 155 PSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKL 234 (360)
Q Consensus 155 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~ 234 (360)
|.+++++.......+++.++++++ ++++++++++.++.++..++..+++++..+.++|++|++|+|++++..+++..+
T Consensus 1 P~~~~~~~~~~~~~~~~~~~~~~g--~~~~a~~~i~~~~~~~~~~~~~g~~~a~~~~~s~~~G~~~~~~~~~~~~~~~~~ 78 (162)
T PF01554_consen 1 PIALMQLLQVLGFIIDTIFVGRLG--PEALAAYGIASSIFSILFMLIFGLATALQILISQNIGAGDYKRAKKVVRQGLLL 78 (162)
T ss_dssp HHHHHHHHHHHHHHHHHHCCHCCT--TCCCCHCCHHHHHHHHHHHHHHHHHHHHHHHHCCCCCSSSTTTCCCHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhC--HHHHHHHHHHHHHHHHHhhhcccccccccceeeccccccccccccccccccccc
Confidence 889999999999999999999997 899999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHH
Q 018141 235 SVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMP 314 (360)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~ 314 (360)
+.+++++.++....+++++.++|++|+|+.+.+.+++++..++.++.+......+++++.||++.+++.++.+.|++++|
T Consensus 79 ~~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~ 158 (162)
T PF01554_consen 79 SLIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMYISIISFWIINIP 158 (162)
T ss_dssp HHHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHHHHHHHHHHHHHH
T ss_pred chhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998899999
Q ss_pred HHHH
Q 018141 315 IAAI 318 (360)
Q Consensus 315 ~~~~ 318 (360)
++|+
T Consensus 159 l~yl 162 (162)
T PF01554_consen 159 LAYL 162 (162)
T ss_dssp HHHH
T ss_pred HHhC
Confidence 9885
No 24
>TIGR02900 spore_V_B stage V sporulation protein B. SpoVB is the stage V sporulation protein B of the bacterial endopore formation program in Bacillus subtilis and various other Firmcutes. It is nearly universal among endospore-formers. Paralogs with rather high sequence similarity to SpoVB exist, including YkvU in B. subtilis and a number of proteins in the genus Clostridium. Member sequences for the seed alignment were chosen to select those proteins, no more than one to a genome, closest to B. subtilis SpoVB in a neighbor joining tree.
Probab=99.60 E-value=1.1e-13 Score=130.57 Aligned_cols=197 Identities=15% Similarity=0.146 Sum_probs=164.8
Q ss_pred HHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHhhcCCChHHHHHHH
Q 018141 150 LKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITY-GLSAAASTRVSNELGAGNPDQAKNAM 228 (360)
Q Consensus 150 l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~-~i~~a~~~~~~~~~g~~~~~~~~~~~ 228 (360)
.|-+.|.++++.........++.++++.. |+++.|+++.+..+..+...+.. |++++..+.++|..|++|+++.++..
T Consensus 2 ~~~~~~~~~~~~~~~~~~~i~~~~l~r~L-g~~~~G~~~~~~~~~~~~~~~~~~Gl~~a~~~~is~~~~~~~~~~~~~~~ 80 (488)
T TIGR02900 2 LKGTFILTIANLITRILGFIFRIVLSRIL-GAEGVGLYGMAMPIYFLFITLTTGGLPVAISKFVAEASAKNDRKNIKKIL 80 (488)
T ss_pred hHhHHHHHHHHHHHHHHHHHHHHHHHHHh-CHHHhhHHHHHHHHHHHHHHHHhCCcHHHHHHHHHHHHhccchhhHHHHH
Confidence 46788999999999999999999999864 38899999999999888887764 99999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHH
Q 018141 229 AVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATF 308 (360)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 308 (360)
+.+..+....+++.++++..+++++...+.+|++. ..+++++++..++..+.....+.+|+.||.+..+..+..+.
T Consensus 81 ~~~~~l~l~~~~~~~~l~~~~~~~i~~~~~~~~~~----~~~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~i~~ 156 (488)
T TIGR02900 81 KVSLIFTLIWSLIVTAIVFLLSPFIASTLLKDERS----LYSLLVICPAMPFIALSSVLKGYFQGISNMKPPAYIQVIEQ 156 (488)
T ss_pred HHHHHHHHHHHHHHHHHHHHhhHHHHHHHcCChhH----HHHHHHHHHHHHHHHHHHHHHHHHhhhccchHhHHHHHHHH
Confidence 99999999999999999999999998877666643 34678889999999999999999999999999999999885
Q ss_pred HHHHHHHHHHHHH-----HhCCCcceehHHHHHHHHHHHHHHHHHHhcc
Q 018141 309 YFIGMPIAAILGF-----KLSLYVKGLWIGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 309 ~~~~i~~~~~l~~-----~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~ 352 (360)
++++.....+.. ..++++.|+++++.++..+..+...++++|+
T Consensus 157 -i~~~~~~~~~~~~~~~~~~~~~v~g~~~~~~i~~~~~~~~~~~~~~~~ 204 (488)
T TIGR02900 157 -IVRISVVALLISAFLPYGLEYAVAGAYLSLVLGELVSLLYLYFFFKRK 204 (488)
T ss_pred -HHHHHHHHHHHHHHHhcChHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 666554433322 2245677888888889888888766555443
No 25
>KOG1347 consensus Uncharacterized membrane protein, predicted efflux pump [General function prediction only]
Probab=99.60 E-value=1.7e-13 Score=126.31 Aligned_cols=206 Identities=17% Similarity=0.155 Sum_probs=191.7
Q ss_pred HHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHHhhcCCCh
Q 018141 143 FSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESV-AYMITYGLSAAASTRVSNELGAGNP 221 (360)
Q Consensus 143 ~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~-~~~~~~~i~~a~~~~~~~~~g~~~~ 221 (360)
+++.|++.+++.|..+....+.....++..++||.| +.++++.++++...+. ...+..+++.+..|.++|++|++++
T Consensus 24 ~~e~k~l~~ia~P~i~~~~~~~~~~~is~~f~GhlG--~leLaa~sla~s~~n~~~~s~~~gl~~aletlcgQa~ga~~~ 101 (473)
T KOG1347|consen 24 VTESKELARLALPAILTFLAQPLLSLVSTAFAGHLG--NLELASVSLANSFANITGVSILLGLQLALDTLCGQAFGAKKF 101 (473)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhHHhhhcccc--chHHHHHHHHHHhhcccchHHhhccchhhhcchHhhhccccc
Confidence 688999999999999999999999999999999998 7799999999888776 6678889999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHH
Q 018141 222 DQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAV 301 (360)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 301 (360)
+......+++.......+++.+. ++.+.+++...+++|+++...+..|.++..+..+-......+..++|++++.....
T Consensus 102 ~~lg~~lqrs~~~l~~~~~~~~~-l~~~~~~il~~lgq~~~i~~~a~~y~~~~ip~~~a~~~~~~l~~~lq~Q~~~~~~~ 180 (473)
T KOG1347|consen 102 TALGVYLQRSGIVLLVQGLPISL-LILNSEPILLLLGQDPDISRDAGSYAFMLIPGLFSYAVSFPLAKFLQAQSITLPLL 180 (473)
T ss_pred chhhHHHHHHHHHHHHHHHHHHH-HHHccHHHHHHhCCChhHHHHHhhhHhhhcchhhhhHHHHHHHHHHHhccCchHHH
Confidence 99999999999999999999965 56677999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhcc
Q 018141 302 WANLATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 302 ~~~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~ 352 (360)
+.+... .+++++++|++...+++|..|++++..++++........+....
T Consensus 181 ~~~~~~-~~lhi~~~~llv~~~~~g~~Gaala~~~s~w~~~~~l~~yi~~~ 230 (473)
T KOG1347|consen 181 VIGLVA-LVLHILLTWLLVSKLGLGIKGAALALVASYWLNVRILLLYAVLS 230 (473)
T ss_pred HHHHHH-HHHHHHHHHHhhhcccCCCccchHHHHHHHHHHHHHHHHHheec
Confidence 999999 59999999999999999999999999999999998877776544
No 26
>TIGR01695 mviN integral membrane protein MviN. This model represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII.
Probab=99.51 E-value=4.5e-12 Score=120.13 Aligned_cols=197 Identities=15% Similarity=0.048 Sum_probs=154.2
Q ss_pred HHHhHhHhHHHHHHHHHHHHHHHHHhcC-CCChhHHH-HHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHhhcCCChHHH
Q 018141 149 ILKLALPSAAMVCLEYWAFEILVFLAGL-MPNSELTT-SLIAMCVNTESVAYMITY--GLSAAASTRVSNELGAGNPDQA 224 (360)
Q Consensus 149 ~l~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-a~~~~~~~i~~~~~~~~~--~i~~a~~~~~~~~~g~~~~~~~ 224 (360)
+.|-+.-....++...+...+|..++++ +| +++. ++|+.+.++.+....+.. |++++..|...+..+++ |++
T Consensus 2 ~~k~~~i~~~~~~~~~~~~~~~~~~~a~~lG--~~~~~~~~~~~~~i~~~~~~~~~~~g~~~a~i~~~~~~~~~~--~~~ 77 (502)
T TIGR01695 2 LLKSTLIVSLGTLFSRITGFVRDAIIASAFG--AGLTADAFNVAFVIPNFFRRLFAEGAFNSAFVPVFTKAKKKE--KEA 77 (502)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHhC--CChHhhHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHhhh--hHH
Confidence 3455666777888888888899999998 56 7778 899999999877765543 68899888887664433 567
Q ss_pred HHHHHHHHHHHHHH-HHHHHHHHHhhhhhhccccC--CcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHH
Q 018141 225 KNAMAVTVKLSVLL-ALVVVLALGFGHNIWAGFFS--NSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAV 301 (360)
Q Consensus 225 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~l~~--~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~ 301 (360)
++....+....... .+..+++.+++++++.+++. .|+|..+.+.++++++.++.++..+.....+.+|+.||.+.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~g~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 157 (502)
T TIGR01695 78 RRAFANTVTTLLILSLLLVVLIGIFFAPFVISLLAPGFADETRSLAVSLTRIMFPYLLLISLAAVFGGILNARKRFFIPS 157 (502)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCeeHHHH
Confidence 76666666655544 44456778889999999883 3666678999999999999999999999999999999999999
Q ss_pred HHHHHHHHHHHHHHHHHHHHHhCCCcceeh--HHHHHHHHHHHHHHHHHHhcc
Q 018141 302 WANLATFYFIGMPIAAILGFKLSLYVKGLW--IGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 302 ~~~~~~~~~~~i~~~~~l~~~~~~g~~G~~--~a~~~~~~~~~i~~~~~~~~~ 352 (360)
+.++..+ +.++...++. .+++|..|++ +++.++..+..+...++.+|+
T Consensus 158 ~~~i~~~-i~~i~~~~~~--~~~~g~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 207 (502)
T TIGR01695 158 FSPILFN-IGVILSLLFF--DWNYGQYSLALAIGVLIGGVAQLLIQLPFLRKA 207 (502)
T ss_pred HHHHHHH-HHHHHHHHHH--HcccchHHHHHHHHHHHHHHHHHHHHHHHHHHC
Confidence 9999886 5555543333 5678999988 999999999888776655543
No 27
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=99.46 E-value=4.4e-11 Score=103.84 Aligned_cols=154 Identities=16% Similarity=0.182 Sum_probs=132.4
Q ss_pred HHHHHHHHHHHHHHHcCchhHHHHHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhcccccccc
Q 018141 56 VAYGVIQNILRFLQTQSIVIPLIFFSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTW 135 (360)
Q Consensus 56 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~ 135 (360)
+..........++|+.++.+.....++...+...++...++.. +.+..+..++..++..+..++...+.+++.+
T Consensus 120 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 193 (273)
T PF01943_consen 120 ILSSLSSVFSGLLQGLQRFKYIAISNIISSLLSLLLILLLLFL-GSSLWGFLLGLVISSLVSLIISLFYLRRKLR----- 193 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHc-----
Confidence 5788889999999999999999999999999998877776664 4458899999999999998888877754332
Q ss_pred CCCCHHhHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 018141 136 EGFSFESFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNE 215 (360)
Q Consensus 136 ~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~ 215 (360)
++.++.+++..|++++++.|..+.++...+....|..+++++. |++++|.|+.+.++......+..++.++..|.+++.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ii~~~~-g~~~vg~Y~~a~~l~~~~~~~~~~~~~~~~P~~s~l 272 (273)
T PF01943_consen 194 PRFSFFSKKFFKEILRFGLPLFLSSLLSWLYSQIDRLIIGYFL-GPEAVGIYSVAYRLASAISFLLSSISTVLFPRLSRL 272 (273)
T ss_pred ccccccchHHHHHHHHHHHHHHHHHHHHHHHHHhHHHHHHHhC-CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh
Confidence 1222234789999999999999999999999999999999987 589999999999999999999999999999999986
Q ss_pred h
Q 018141 216 L 216 (360)
Q Consensus 216 ~ 216 (360)
+
T Consensus 273 ~ 273 (273)
T PF01943_consen 273 W 273 (273)
T ss_pred C
Confidence 3
No 28
>PRK15099 O-antigen translocase; Provisional
Probab=99.38 E-value=4.4e-11 Score=110.57 Aligned_cols=191 Identities=12% Similarity=0.041 Sum_probs=147.8
Q ss_pred HHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHhhcCCChHHHHHHH
Q 018141 150 LKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMI-TYGLSAAASTRVSNELGAGNPDQAKNAM 228 (360)
Q Consensus 150 l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~-~~~i~~a~~~~~~~~~g~~~~~~~~~~~ 228 (360)
.|-+......+............+..++- |+++.+.++....+..+...+ ..|++++....++|+ ++|+|+.++..
T Consensus 4 ~k~~~~~~~~~~~~~~~~~l~~~i~ar~L-g~~~~G~~~~~~~~i~~~~~~~~~G~~~a~~~~ia~~--~~~~~~~~~~~ 80 (416)
T PRK15099 4 AKASLWTAASTLVKIGAGLLVVKLLAVSF-GPAGVGQAGNFRQLITVLGVLAGAGIFNGVTKYVAQY--HDQPQQLRAVV 80 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhc-CcHHHHHHHHHHHHHHHHHHHHcCCccceeeeeHHhc--CCCHHHHHHHH
Confidence 44455555666666655555555555555 488999988888888877766 668888888888887 68889999999
Q ss_pred HHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHH
Q 018141 229 AVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATF 308 (360)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~ 308 (360)
+.++......+++.+++.+.+.+++...+.+|+| + ..+..+..+..+...+.....+.+|+.||++.++...+.+.
T Consensus 81 ~~~~~l~~~~~~i~~~~~~~~~~~i~~~~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~lr~~~~~~~~~~~~~~~~ 156 (416)
T PRK15099 81 GTSSAMVLGFSTLLALVFLLAAAPISQGLFGHTD-Y---QGVVRAVALIQMGIAWANLLLAILKGFRDAAGNALSLIVGS 156 (416)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCChh-H---HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999988877665 3 34566666666677888899999999999999999999885
Q ss_pred HHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHh
Q 018141 309 YFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITL 350 (360)
Q Consensus 309 ~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~ 350 (360)
++++.+ .++... ..|+.|+++++.+++.+..+...++.+
T Consensus 157 -~~~i~l-~i~~~~-~~Gv~Ga~iat~i~~~i~~~~~~~~~~ 195 (416)
T PRK15099 157 -LIGVAA-YYLCYR-LGGYEGALLGLALVPALVVLPAGIMLI 195 (416)
T ss_pred -HHHHHH-HHHHHH-HhcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 777666 333222 239999999999999998776555444
No 29
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=99.28 E-value=6.2e-09 Score=89.22 Aligned_cols=159 Identities=14% Similarity=0.194 Sum_probs=126.7
Q ss_pred HHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHH
Q 018141 46 LYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFFSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYV 125 (360)
Q Consensus 46 ~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~ 125 (360)
.++....+..+........++.+++++|.+.....+....+...++...+.+ .+.+..+..++..+++.+..++.+...
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (251)
T PF13440_consen 92 WLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRSLLRLLLLVLLLY-LGLNLWSILLAFIISALLALLISFYLL 170 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHHHHHHHHHHHHHHHHHHh
Confidence 3466777888889999999999999999999999999999988555444444 344888899999999988877766533
Q ss_pred HhccccccccCCCCHHhHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHH-HHHHHH
Q 018141 126 LCAKKFEHTWEGFSFESFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAY-MITYGL 204 (360)
Q Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~-~~~~~i 204 (360)
+ ++ .+.. + +.+..| .++.+.|....+.........|..+++.+. |++++|.|+.+.++..... .+..++
T Consensus 171 ~--~~--~~~~---~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l-~~~~~g~y~~a~~l~~~~~~~~~~~i 240 (251)
T PF13440_consen 171 R--RK--LRLS---F-KFSWRR-LLKYGLPFSLSSLLSWLLSQIDRLLIGYFL-GPEAVGIYSVAQRLASLPASLLSSAI 240 (251)
T ss_pred c--cc--cCCC---c-hhhHHH-HHHHHHHHHHHHHHHHHHHHHHHHHHHHHc-CHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 2 11 1111 1 123334 799999999999999999999999999944 4899999999999999888 999999
Q ss_pred HHHHHHHHHHh
Q 018141 205 SAAASTRVSNE 215 (360)
Q Consensus 205 ~~a~~~~~~~~ 215 (360)
++...|.++|.
T Consensus 241 ~~~~~p~lar~ 251 (251)
T PF13440_consen 241 SSVFFPKLARM 251 (251)
T ss_pred HHHHHHHHhCC
Confidence 99999999863
No 30
>PF03023 MVIN: MviN-like protein; InterPro: IPR004268 This entry represents MviN, a family of integral membrane proteins predicted to have ten or more transmembrane regions. Although frequently listed as a virulence protein, it is not restricted to pathogens and it is an essential protein in Sinorhizobium meliloti. In a number of species its gene is adjacent to that of the uridylyltransferase GlnD, the signal-transducing enzyme that performs the key modification to the nitrogen regulatory protein PII []. Disruption of the MviN open reading frame results in flagellar structures that contain only the basal body and hook complex that lack the flagellum; suggesting that MviN might be involved in flagellin export or assembly []. Genome comparison studies led to MviN being predicted to be a peptidoglycan lipid II flippase though currently there is no direct evidence to support this annotation [].
Probab=99.27 E-value=8.6e-10 Score=102.50 Aligned_cols=173 Identities=16% Similarity=0.095 Sum_probs=148.1
Q ss_pred CCCChhHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhh
Q 018141 176 LMPNSELTTSLIAMCVNTESVAYMIT--YGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLALVVVLALGFGHNIW 253 (360)
Q Consensus 176 ~~~~~~~~~a~~~~~~~i~~~~~~~~--~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 253 (360)
.+|. +.+..+|.++.++.+++..+. .+++++..|...+.. ++|+|+.++..+.......+....++++..++++++
T Consensus 4 ~fG~-s~~~Daf~~A~~ip~~l~~l~~~gal~~~~IP~~~~~~-~~~~~~~~~f~~~~~~~~~~~~~~l~~l~~lfa~~i 81 (451)
T PF03023_consen 4 FFGA-SAEADAFFVAFTIPNFLRSLLAGGALSAAFIPVFSKAR-EKGEEEARRFISTLLTILLIISLLLTLLGILFAPPI 81 (451)
T ss_pred HhcC-CchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3453 567889999999999987554 478999999999999 899999999999999999999999999999999999
Q ss_pred ccccCC--cHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhCCC---cc
Q 018141 254 AGFFSN--SPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAILGFKLSLY---VK 328 (360)
Q Consensus 254 ~~l~~~--~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~~~~~~g---~~ 328 (360)
.+++.+ |+|..+.+.+.+++..+..++.++.....+++|+.+|-..+....+..+ +..+...++. ....| +.
T Consensus 82 v~~la~g~~~~~~~la~~l~~i~~~~~~~~~l~~i~~a~L~~~~~F~~~~~~~l~~N-~~~I~~~~~~--~~~~~~~~i~ 158 (451)
T PF03023_consen 82 VRLLAPGFSPETIELAVQLLRILAPSILFIGLSSIFSAILNAHRRFLIPALSPLLFN-LSIILSLLLL--SNSWGQENIY 158 (451)
T ss_pred HHHHCCCCChHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCcchHHHHHHHHHH-HHHHHHHHHH--HHhcCchHHH
Confidence 999954 6788999999999999999999999999999999999999999888876 4444433444 34467 88
Q ss_pred eehHHHHHHHHHHHHHHHHHHhccC
Q 018141 329 GLWIGLICGLFCQASSLLLITLRRK 353 (360)
Q Consensus 329 G~~~a~~~~~~~~~i~~~~~~~~~~ 353 (360)
+.++|..++..+..+......+|..
T Consensus 159 ~la~g~~~g~~~~~l~~l~~~~~~~ 183 (451)
T PF03023_consen 159 ALAWGVLIGAIIQFLIQLPYLRRFG 183 (451)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHCC
Confidence 8999999999999988888777654
No 31
>COG0728 MviN Uncharacterized membrane protein, putative virulence factor [General function prediction only]
Probab=99.03 E-value=1.3e-07 Score=87.38 Aligned_cols=206 Identities=12% Similarity=0.048 Sum_probs=165.3
Q ss_pred hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH--HHHHHHHHHHHHhhcCC
Q 018141 142 SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITY--GLSAAASTRVSNELGAG 219 (360)
Q Consensus 142 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~--~i~~a~~~~~~~~~g~~ 219 (360)
+.+..|.....+.-..++.+...+- |..+...+|. .....+|.++.++.+++..+.. +++++..|...+...++
T Consensus 6 ~~sllks~~~vs~~Tl~SRi~G~vR---d~~iA~~fGa-~~~aDAF~vAf~iPN~lRrlfaegafs~aFVPv~~~~~~~~ 81 (518)
T COG0728 6 KMSLLKSLIIVSSATLLSRILGFVR---DVLIAAAFGA-GAAADAFFVAFKLPNLLRRLFAEGAFSSAFVPVLAEAKKKE 81 (518)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHH---HHHHHHHhCC-chHHHHHHHHHHhHHHHHHHHhchhHhhhhhHHHHHHHHcc
Confidence 4667888888888887777777666 7777777773 4678899999999999887754 77899999999999988
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhc-cccCC--cHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccc
Q 018141 220 NPDQAKNAMAVTVKLSVLLALVVVLALGFGHNIWA-GFFSN--SPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGW 296 (360)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-~l~~~--~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~ 296 (360)
+.|+.++..+........+.+..+++..++++++. .++.+ |++....+....++..+..++.++.....+.+++.+|
T Consensus 82 ~~~~~~~f~~~v~~~l~~~ll~vt~L~~l~~p~iv~~~~~~g~~~~~~~~a~~l~~i~~Pyl~~isL~al~~aiLNs~~~ 161 (518)
T COG0728 82 GEEAARFFSRLVTGLLTLVLLLVTLLGILFAPWLVRLLLAPGFDETDKFLAVLLTRILFPYLLFISLSALFGAILNSRNR 161 (518)
T ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCCCchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHhccCe
Confidence 88889999988887888888888889999999999 44444 3443446888899999999999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhcc
Q 018141 297 QHLAVWANLATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLRR 352 (360)
Q Consensus 297 ~~~~~~~~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~~ 352 (360)
-..+...-+..+ +..+....++....+....+.+++..++-+...+......+|.
T Consensus 162 F~~~a~aPvl~N-v~~I~~~l~~~~~~~~~~~~La~gvl~Gg~~Q~l~~lp~l~~~ 216 (518)
T COG0728 162 FFIPAFAPVLLN-VSVIGLALFLGPYFDPPLLALAWGVLIGGLLQLLVQLPALRKA 216 (518)
T ss_pred echhhhhHHHHH-HHHHHHHHHhccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHc
Confidence 999999888776 4444344444333222356788889999999999988888775
No 32
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=98.76 E-value=6e-06 Score=77.89 Aligned_cols=204 Identities=15% Similarity=0.039 Sum_probs=158.6
Q ss_pred HHHHHHhHhHhHHHHHHHHHHHHHHHHHhcC--CCChhHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHHHHhhcCCCh-
Q 018141 146 ILTILKLALPSAAMVCLEYWAFEILVFLAGL--MPNSELTTSLIAMCVNTESVA-YMITYGLSAAASTRVSNELGAGNP- 221 (360)
Q Consensus 146 ~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~a~~~~~~~i~~~~-~~~~~~i~~a~~~~~~~~~g~~~~- 221 (360)
-++.++.....+.+.+.-.+...-|..++.. +. ..++-|.|+++++.-++. -.+...+-.+.....++...+++.
T Consensus 252 d~~~l~l~~~~~~Qsi~K~lLTEGdk~vl~~~~~~-t~~~QGvY~lv~N~GSLvaR~lF~PiEEs~~~~Fsk~l~~~~~~ 330 (549)
T PF04506_consen 252 DRDLLSLTWSFFFQSILKHLLTEGDKLVLSFFNLL-TFEDQGVYALVSNYGSLVARLLFQPIEESSRLYFSKLLSRDNSK 330 (549)
T ss_pred CHHHHHHHHHHHHHHHHHHHHhhCCeEEEEeeccC-CHHHhhHHHHHhhHHHHHHHHHhCcHHHHHHHHHHHHhcccCch
Confidence 4788999999999999999999999999888 66 388999999999997775 466778888888888888765533
Q ss_pred --------HHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhh
Q 018141 222 --------DQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARG 293 (360)
Q Consensus 222 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~ 293 (360)
++..+.....++....++++...+-...++.+.+++.+++-.-..+...++.++...++.+++.+...+.++
T Consensus 331 ~~~~~~~~~~~~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi~EaF~~s 410 (549)
T PF04506_consen 331 KKQPQESLKQAANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGITEAFVFS 410 (549)
T ss_pred hhccchhHHHHHHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccHHHHHHHH
Confidence 345666777777888888777777777888888888664433344688899999999999999999999999
Q ss_pred ccchhHHHHHHHHHH--HHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 294 CGWQHLAVWANLATF--YFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 294 ~g~~~~~~~~~~~~~--~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
..+.+.....+-.-. .++-+..++.+... ++|..|.-+|..+...++.+...++.+|
T Consensus 411 ~a~~~~l~~~~~~m~~~S~~f~~~~~~l~~~-~~G~~GlI~AN~iNM~lRI~ys~~fI~~ 469 (549)
T PF04506_consen 411 VASESQLDRYNYWMVVFSAIFLAASYLLTRW-GLGAVGLILANCINMSLRIIYSLRFIRR 469 (549)
T ss_pred hCCHHHHHHHHHHHHHHHHHHHHHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHHHH
Confidence 988776655444321 13444566777554 6899999999998888888877666554
No 33
>PF01554 MatE: MatE; InterPro: IPR002528 Characterised members of the Multi Antimicrobial Extrusion (MATE) family function as drug/sodium antiporters. These proteins mediate resistance to a wide range of cationic dyes, fluroquinolones, aminoglycosides and other structurally diverse antibodies and drugs. MATE proteins are found in bacteria, archaea and eukaryotes. These proteins are predicted to have 12 alpha-helical transmembrane regions, some of the animal proteins may have an additional C-terminal helix. ; GO: 0015238 drug transmembrane transporter activity, 0015297 antiporter activity, 0006855 drug transmembrane transport, 0055085 transmembrane transport, 0016020 membrane; PDB: 3MKU_B 3MKT_B.
Probab=98.66 E-value=1.2e-08 Score=81.24 Aligned_cols=94 Identities=18% Similarity=0.328 Sum_probs=89.0
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHH
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIF 79 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 79 (360)
++++.++.++.+....+++.+++ ..+.+++..+++.|+|+.+.+.+|+++..++.|+..+....++++|+.||++.++.
T Consensus 67 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~g~~~~~~~ 146 (162)
T PF01554_consen 67 RAKKVVRQGLLLSLIIGLLLSLVLLLFSEFILSLFGNDPEVIEIARQYLRIMAFSIPFFALFFVFSGILQGIGRTKIAMY 146 (162)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCHCTSSSTTCCHHHHHHHHCCHHHHHHHHHHHHHHCCCCGCCSTHCCCHH
T ss_pred ccccccccccccchhcccchhhhhhhHHHHHHHHhhhhHHHHHHhhccchhhhhHHHHHHHHHHHHHHHHHCCcHHHHHH
Confidence 45678999999999999999998 88999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHH-HHHHHHHHH
Q 018141 80 FSALPM-AIHFGIAYA 94 (360)
Q Consensus 80 ~~~~~~-~~~i~l~~~ 94 (360)
.+++.. ++|+.++++
T Consensus 147 ~~~~~~~~~~i~l~yl 162 (162)
T PF01554_consen 147 ISIISFWIINIPLAYL 162 (162)
T ss_dssp HHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhHHhC
Confidence 999999 999999874
No 34
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=98.65 E-value=8.7e-05 Score=66.21 Aligned_cols=295 Identities=15% Similarity=0.042 Sum_probs=176.8
Q ss_pred hHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHHHHHHHHH-HhhhcC-CCcchhHHHHHHHHHHHHH-HHHHHHHhccc
Q 018141 54 GLVAYGVIQNILRFLQTQSIVIPLIFFSALPMAIHFGIAYA-FVYLTS-LGFKGASLAASVSLWISML-MLVTYVLCAKK 130 (360)
Q Consensus 54 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~-~i~~~~-~g~~g~ala~~i~~~~~~~-~~~~~~~~~~~ 130 (360)
+...-....-+.-..|...+.+.-++..-+...+.-+..+. ++.+.+ .++.--|+|.......-.+ +.+.|.+.++.
T Consensus 132 S~vvELlsEp~~iv~Q~~~~~~~~~i~e~l~~~v~~i~~fa~lv~~~~~~~l~~FAlaql~~~itl~l~y~~~Yf~~~~s 211 (530)
T KOG2864|consen 132 SIVVELLSEPLYIVSQCGLKVQLRAIAEGLATIVKCIVLFAGLVMGPNMYALLAFALAQLAYAITLLLCYYWFYFYIRGS 211 (530)
T ss_pred HHHHHHhcccHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHhcCchhHHHHHHHHHHHhhHHHHHHHHHHHHHHcCC
Confidence 33333333334444555556666666666666666333333 333333 3444556666655554444 23334433331
Q ss_pred ccc---------ccCCCCHH--hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCC-hhHHHHHHHHHHHHHHHH-
Q 018141 131 FEH---------TWEGFSFE--SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPN-SELTTSLIAMCVNTESVA- 197 (360)
Q Consensus 131 ~~~---------~~~~~~~~--~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~a~~~~~~~i~~~~- 197 (360)
... ..++.... ....-++..+.......+...-++...-|..++....- +-.+-|.|.++++.-.++
T Consensus 212 ~~~~~~~~r~Sdllpk~~~n~~~~ffd~d~~~~~~s~~~Qs~lKqlLTeGdkyvmt~~~~ls~~~QgvYd~v~n~GSLla 291 (530)
T KOG2864|consen 212 IPETEPFSRFSDLLPKVSENERGIFFDNDLLKLTKSFTFQSFLKQLLTEGDKYVMTFTELLSFGDQGVYDLVSNYGSLLA 291 (530)
T ss_pred cccccchhhhhhhccCCCCCCccccccHHHHHHHHHHHHHHHHHHHhhcccceeEeeeccCCcchhhHHHHHHhhhhHHH
Confidence 110 01111110 01122445555555556666666666667776663321 144678899998886664
Q ss_pred HHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHH---HHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHH
Q 018141 198 YMITYGLSAAASTRVSNELGAGNPDQAKNAMAV---TVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLL 274 (360)
Q Consensus 198 ~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~ 274 (360)
-++...+-.......+|...+++.|+.|+.... .++....+++....+-...++.+..++++++-.-..+...++++
T Consensus 292 R~iF~PIEEss~~~FA~~ls~~~qe~~k~a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~Y 371 (530)
T KOG2864|consen 292 RLIFRPIEESSYIYFARLLSRDNQENVKKAVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWY 371 (530)
T ss_pred HHHhChhHHHHHHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHH
Confidence 466778889999999999988887777766554 44455555555555555667777787776543333466889999
Q ss_pred HHHHHHHhHHHHHHHHHhhccchhHHHHHH---HHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 275 ALSITLDSVQGVLSGVARGCGWQHLAVWAN---LATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 275 ~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~---~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
|...++.+++.+..++..+.++.+..-.-+ ++.+ ++-+..+|++.. .+|..|.-+|..+...++-+...+++++
T Consensus 372 clYI~~lAiNGitEaF~~A~~t~~qi~~~n~~mlafS-viflilsylL~~--~~~~~GlIlANiiNm~lRIlys~~fI~~ 448 (530)
T KOG2864|consen 372 CLYIPFLAINGITEAFAFAVATSRQIDKHNKFMLAFS-VIFLILSYLLIR--WFGLVGLILANIINMSLRILYSLRFIRH 448 (530)
T ss_pred HHHHHHHHhccHHHHHHHHhccHHHHHhcccchhHHH-HHHHHHHHHHHH--HhchhHHHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999998777655433 2332 455678888854 4688887777777777666655544443
No 35
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=98.48 E-value=3.2e-05 Score=60.26 Aligned_cols=77 Identities=18% Similarity=0.297 Sum_probs=71.2
Q ss_pred HHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHH
Q 018141 48 MKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFFSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVL 126 (360)
Q Consensus 48 ~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~ 126 (360)
+++.+++.++..+.....+.+++.||+|..+....++.++|++++++++. ++|..|+++++.+++.+......++.+
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~~~v~i~~~~~li~--~~G~~Gaa~a~~i~~~~~~~~~~~~~~ 78 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIGAIVNIILNYILIP--RFGIYGAAIATAISEIVSFILNLWYVR 78 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHHHHHHHHHHHHHHH--HHHHhHHHHHHHHHHHHHHHHHHHHHH
Confidence 57888999999999999999999999999999999999999999999964 689999999999999999888877775
No 36
>PF14667 Polysacc_synt_C: Polysaccharide biosynthesis C-terminal domain
Probab=98.47 E-value=8.9e-07 Score=69.11 Aligned_cols=79 Identities=15% Similarity=0.126 Sum_probs=73.9
Q ss_pred HHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHh
Q 018141 271 TPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITL 350 (360)
Q Consensus 271 l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~ 350 (360)
+++++++.++.+.+...+..+++.||+|..++.++.+ .+++++.++.+ .+++|..|+++++.+++.+......+..+
T Consensus 2 l~il~~~~~~~~l~~~~~~il~~~~k~~~~~~~~~~~-~~v~i~~~~~l--i~~~G~~Gaa~a~~i~~~~~~~~~~~~~~ 78 (146)
T PF14667_consen 2 LQILALAIIFMGLSQPLGSILQAMGKTKWPFIITLIG-AIVNIILNYIL--IPRFGIYGAAIATAISEIVSFILNLWYVR 78 (146)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHcCCchHHHHHHHHH-HHHHHHHHHHH--HHHHHHhHHHHHHHHHHHHHHHHHHHHHH
Confidence 6789999999999999999999999999999999999 59999999999 77899999999999999999999888887
Q ss_pred cc
Q 018141 351 RR 352 (360)
Q Consensus 351 ~~ 352 (360)
|.
T Consensus 79 k~ 80 (146)
T PF14667_consen 79 KK 80 (146)
T ss_pred HH
Confidence 75
No 37
>PF01943 Polysacc_synt: Polysaccharide biosynthesis protein; InterPro: IPR002797 Members of this family are integral membrane proteins [], and many are implicated in the production of polysaccharide. The family includes RfbX part of the O antigen biosynthesis operon [], and SpoVB from Bacillus subtilis (Q00758 from SWISSPROT), which is involved in spore cortex biosynthesis [].; GO: 0000271 polysaccharide biosynthetic process, 0016020 membrane
Probab=98.45 E-value=9.3e-05 Score=63.97 Aligned_cols=187 Identities=17% Similarity=0.174 Sum_probs=115.1
Q ss_pred HhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHHhhcCCChHHHHHHHH
Q 018141 151 KLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMI-TYGLSAAASTRVSNELGAGNPDQAKNAMA 229 (360)
Q Consensus 151 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~-~~~i~~a~~~~~~~~~g~~~~~~~~~~~~ 229 (360)
|-+.-....+............+..+.. |+++.|.|+....+.++...+ ..|++++.....++..++ +++.++...
T Consensus 3 k~~~~~~~~~~~~~~~~~~~~~il~r~l-~~~~~G~~~~~~~~~~~~~~~~~~G~~~~~~r~~~~~~~~--~~~~~~~~~ 79 (273)
T PF01943_consen 3 KNSLWLFLSNILSALIGFITIPILARYL-GPEEYGIYSLALSIVSLLSILADLGLSQAIVRFIAEYKDK--KELRSAYFS 79 (273)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHh-CHHHhHHHHHHHHHHHHHHHHHhhhhHHHHHHHHHHhhhh--HHHHHHHHH
Confidence 3344445555555555555555555554 389999999999999888876 668999988888876443 233334443
Q ss_pred HHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHH
Q 018141 230 VTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFY 309 (360)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~ 309 (360)
.......+.++... ....... .+..++ . + ..+........++..........+++.++.+.....++...
T Consensus 80 ~~~~~~~~~~~i~~-~~~~~~~----~~~~~~-~-~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 149 (273)
T PF01943_consen 80 SVLFLLLIFSLIFL-LILLIAS----FFGNPS-L-S--LILIILALLILILSSLSSVFSGLLQGLQRFKYIAISNIISS- 149 (273)
T ss_pred HHHHHHHHHHHHHH-HHHHHHH----HcCCch-H-H--HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-
Confidence 33333333333222 2222222 333332 1 1 11222222222578888889999999999999999998886
Q ss_pred HHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 310 FIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 310 ~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
+........+... +.+..+...+..++..+..+...+..+|
T Consensus 150 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (273)
T PF01943_consen 150 LLSLLLILLLLFL-GSSLWGFLLGLVISSLVSLIISLFYLRR 190 (273)
T ss_pred HHHHHHHHHHHHH-hhhHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 5555444444333 3348888889999988888777666664
No 38
>PRK10459 colanic acid exporter; Provisional
Probab=98.45 E-value=3.5e-05 Score=73.02 Aligned_cols=184 Identities=13% Similarity=0.067 Sum_probs=127.8
Q ss_pred HHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHhhcCCChHHHH
Q 018141 147 LTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMIT-YGLSAAASTRVSNELGAGNPDQAK 225 (360)
Q Consensus 147 ~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~-~~i~~a~~~~~~~~~g~~~~~~~~ 225 (360)
++..+-+....+.+........+...+.+++- ++++.|.++.+..+..+...+. .|++++.. +. .++++
T Consensus 5 ~~~~~g~~w~~~~~~~~~~~~~i~~~ilaR~L-~p~~~G~~~~~~~~~~~~~~~~~~Gl~~aii----~~-~~~~~---- 74 (492)
T PRK10459 5 EKTISGAKWTAISTVIIIGLQLVQLTVLARIL-DNHQFGLLTMSLVIIGFADTLSDMGIGASII----QR-QDISH---- 74 (492)
T ss_pred HHHHccccHHHHHHHHHHHHHHHHHHHHHHhC-CHHHccHHHHHHHHHHHHHHHHHcCHHHHHH----hc-ccCCH----
Confidence 34455556666777777766666666666665 4889999999999988877665 47777552 21 11222
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHH
Q 018141 226 NAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANL 305 (360)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~ 305 (360)
+............+....++.+.+++++..++. +++ ....+++.++..++.++.......++..+|.+.....+.
T Consensus 75 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~r~~~f~~~a~~~~ 149 (492)
T PRK10459 75 LQLSTLYWLNVGLGIVVFVLVFLLSPLIADFYH-NPE----LAPLIKTLSLAFVIIPIGQQFRALLQKELEFNKLAKIEI 149 (492)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcC-Chh----hHHHHHHHHHHHHHHHHhhHHHHHHHHHhhhHHHHHHHH
Confidence 234445566666677777777788888877654 443 335678888888888888889999999999998888888
Q ss_pred HHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHH
Q 018141 306 ATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLL 347 (360)
Q Consensus 306 ~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~ 347 (360)
... +........+. ..++|..+..++..++..+..+....
T Consensus 150 ~~~-i~~~~~~i~~~-~~~~g~~~l~~~~~~~~~~~~l~~~~ 189 (492)
T PRK10459 150 SAV-VAGFTFAVVSA-FFWPGALAAILGYLVNSSVRTLLFGY 189 (492)
T ss_pred HHH-HHHHHHHHHHH-HHCCcHHHHHHHHHHHHHHHHHHHHH
Confidence 875 45555554443 34678988888988888877765443
No 39
>PF13440 Polysacc_synt_3: Polysaccharide biosynthesis protein
Probab=98.18 E-value=0.00093 Score=57.00 Aligned_cols=164 Identities=16% Similarity=0.232 Sum_probs=106.8
Q ss_pred HHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHh
Q 018141 170 LVFLAGLMPNSELTTSLIAMCVNTESVAYMIT-YGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLALVVVLALGF 248 (360)
Q Consensus 170 ~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~-~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (360)
...++++.. ++++.|.|+....+..+...+. .|+.+...- ..++|+++.++..+.......+..++..++...
T Consensus 7 ~~~~lar~l-~~~~~G~~~~~~s~~~~~~~~~~~g~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 80 (251)
T PF13440_consen 7 FLILLARYL-GPEDFGIYALIFSIVSILSIVASLGLRQSLVR-----SAARDKQDIRSLLRFSLLVSLLLAVILAILAIL 80 (251)
T ss_pred HHHHHHHHC-CHHHhHHHHHHHHHHHHHHHHHHHHHHHHHHH-----hhccCHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 344444444 3889999999999888877763 455544433 234666777777777666655555444433222
Q ss_pred hhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhCCCcc
Q 018141 249 GHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAILGFKLSLYVK 328 (360)
Q Consensus 249 ~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~~~~~~g~~ 328 (360)
... .+ ++++ ...++....+..+.........+.+++.+|.+.......... +........+. ..+.+..
T Consensus 81 ~~~----~~-~~~~----~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~ 149 (251)
T PF13440_consen 81 IAY----FF-GDPE----LFWLLLLLALAIFFSALSQLFRSILRARGRFRAYALIDIVRS-LLRLLLLVLLL-YLGLNLW 149 (251)
T ss_pred HHH----Hh-CChh----HHHHHHHHHHHHHHHHHHHHHHHHHHHcCcHHHHHHHHHHHH-HHHHHHHHHHH-HHHhhHH
Confidence 222 33 3332 334566777788888999999999999999999999999885 44433333333 2233788
Q ss_pred eehHHHHHHHHHHHHHHHHHHh
Q 018141 329 GLWIGLICGLFCQASSLLLITL 350 (360)
Q Consensus 329 G~~~a~~~~~~~~~i~~~~~~~ 350 (360)
+..++..++..+..+......+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~ 171 (251)
T PF13440_consen 150 SILLAFIISALLALLISFYLLR 171 (251)
T ss_pred HHHHHHHHHHHHHHHHHHHHhc
Confidence 8888888888887766555433
No 40
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=97.87 E-value=0.0082 Score=51.65 Aligned_cols=171 Identities=13% Similarity=0.062 Sum_probs=116.2
Q ss_pred hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCC
Q 018141 142 SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGL-MPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGN 220 (360)
Q Consensus 142 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~ 220 (360)
.....++++++-.|..+++....+...+.+.-+++ ..+..+.+|+|+++..+.-++..+...+-+....++.+ +
T Consensus 6 ~~~~y~~li~F~iPLa~ts~~~dl~~qiiNagLAr~~e~~vetLAsfglA~sL~lf~~sp~~~~~~igl~~V~s-----~ 80 (345)
T PF07260_consen 6 SLTSYWPLIRFFIPLAITSLAMDLGEQIINAGLARVQEDPVETLASFGLAYSLMLFFASPLSMFHHIGLVFVNS-----K 80 (345)
T ss_pred ccchHHHHHHHHHHHHHHHHHHhccHHHHHHHHhhccchHHHHHHHHHHHHHHHHHHhChhhhhHHHHHHHhcc-----h
Confidence 34578889999999999999999998888877765 33334669999999999999999988887776665543 2
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHH-HHHHhhhh-hhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchh
Q 018141 221 PDQAKNAMAVTVKLSVLLALVVV-LALGFGHN-IWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQH 298 (360)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~ 298 (360)
+++-+ ........+.+...... +..-.+.. .+-++++.|+++.+.+...+.++.+..+++++....++++.=..++.
T Consensus 81 rsrr~-~vl~~~vag~v~avi~~LIa~TpLG~~li~~lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~s~ 159 (345)
T PF07260_consen 81 RSRRK-AVLCMAVAGAVAAVIHLLIAWTPLGNYLINDLHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRHSW 159 (345)
T ss_pred hhhHH-HHHHHHHHHHHHHHHHHHHHhCchHHHHHHHHhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhcccee
Confidence 22211 11111111221111111 11111122 23345567899999999999999999999999999999988777777
Q ss_pred HHHHHHHHHHHHHHHHHHHHH
Q 018141 299 LAVWANLATFYFIGMPIAAIL 319 (360)
Q Consensus 299 ~~~~~~~~~~~~~~i~~~~~l 319 (360)
.....++.. ....+.....+
T Consensus 160 iV~~aSI~~-v~~qvV~v~~l 179 (345)
T PF07260_consen 160 IVGSASIAD-VIAQVVLVAIL 179 (345)
T ss_pred EeehHHHHH-HHHHHHHHHHH
Confidence 777777766 34444444444
No 41
>COG2244 RfbX Membrane protein involved in the export of O-antigen and teichoic acid [General function prediction only]
Probab=97.85 E-value=0.0012 Score=62.29 Aligned_cols=186 Identities=18% Similarity=0.154 Sum_probs=120.5
Q ss_pred HHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHHHhhcCCChHHHH
Q 018141 147 LTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMIT-YGLSAAASTRVSNELGAGNPDQAK 225 (360)
Q Consensus 147 ~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~-~~i~~a~~~~~~~~~g~~~~~~~~ 225 (360)
++..|-+......+....+...+.....++.- |+++.+.++.+..+..+...+. .|+..+....+++..+++|++..+
T Consensus 6 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lar~l-g~~~~G~~~~~~~~~~~~~~i~~~G~~~ai~r~ia~~~~~~~~~~~~ 84 (480)
T COG2244 6 KKLIKGALWLLLGTLISALLGLITIPLLARLL-GPEGFGLYALALAIIGLFSILADFGLPAAITREIAEYREKGEYLLLI 84 (480)
T ss_pred HHHHhhchHHHHHHHHHHHHHHHHHHHHHHHh-CcccceeeehHHHHHHHHHHHHHcCCcHHHHHHHHHhhcccHHHHHH
Confidence 33444444445555555554444555555444 3889999999999999988887 799999999999988777766666
Q ss_pred HH-HHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHH
Q 018141 226 NA-MAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWAN 304 (360)
Q Consensus 226 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~ 304 (360)
.. ...........+.+.........+. |++ ....+++.....++........+.+|+.++.+......
T Consensus 85 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~-------~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (480)
T COG2244 85 LLSVLLLLLLALILLLLLLLIAYLLAPI-------DPV----LALLLRILSLALLLLPLSSVLRGLFQGFGRFGPLALSI 153 (480)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHhccc-------Chh----hHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcccchhHH
Confidence 66 6666666665555554444433333 232 45568889999999999999999999999999988884
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHH
Q 018141 305 LATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLIT 349 (360)
Q Consensus 305 ~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~ 349 (360)
+.+ .......+.+.. .......++...+............
T Consensus 154 ~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (480)
T COG2244 154 VSS--IFLLAAVFALLF---AALGLAVWALVLGAVVSLLVLLILL 193 (480)
T ss_pred HHH--HHHHHHHHHHHH---HhhhHHHHHHHHHHHHHHHHHHHHH
Confidence 433 222223232321 2344455555666665555444433
No 42
>PF07260 ANKH: Progressive ankylosis protein (ANKH); InterPro: IPR009887 This family consists of several progressive ankylosis protein (ANK or ANKH) sequences. The ANK protein spans the outer cell membrane and shuttles inorganic pyrophosphate (PPi), a major inhibitor of physiologic and pathologic calcification, bone mineralisation and bone resorption []. Mutations in ANK are thought to give rise to Craniometaphyseal dysplasia (CMD) which is a rare skeletal disorder characterised by progressive thickening and increased mineral density of craniofacial bones and abnormally developed metaphyses in long bones [].; GO: 0015114 phosphate ion transmembrane transporter activity, 0035435 phosphate ion transmembrane transport, 0016021 integral to membrane
Probab=97.56 E-value=0.03 Score=48.29 Aligned_cols=159 Identities=11% Similarity=0.039 Sum_probs=95.2
Q ss_pred hcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHHHHHHHHHHhhhcCCCc----chhHH
Q 018141 33 LLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVIPLIFFSALPMAIHFGIAYAFVYLTSLGF----KGASL 108 (360)
Q Consensus 33 ~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~~i~~~~~g~----~g~al 108 (360)
..+.++++.+.++.-+.++.+.-++..+....++++--.++.......++...+..+++..+++.. ++.. .--.+
T Consensus 117 lhgVs~~va~~tr~a~l~L~llPfl~alr~~~qGILik~r~s~iV~~aSI~~v~~qvV~v~~ll~~-~l~~~~pllipil 195 (345)
T PF07260_consen 117 LHGVSPSVAEKTRRAFLYLTLLPFLDALRWIHQGILIKHRHSWIVGSASIADVIAQVVLVAILLSM-HLEPQDPLLIPIL 195 (345)
T ss_pred HhCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHhhHhhhccceeEeehHHHHHHHHHHHHHHHHHcc-ccCccccHHHHHH
Confidence 448899999999999999999888899999999888866666666555555555554444444422 2211 11122
Q ss_pred HHHHHHHHHHHH-HHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcC-CCCh---hHH
Q 018141 109 AASVSLWISMLM-LVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPSAAMVCLEYWAFEILVFLAGL-MPNS---ELT 183 (360)
Q Consensus 109 a~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~ 183 (360)
+...+..+-.-. ++.+...-.+..+........+...+++++++.+|.+.....+...--+.+.++++ ++++ +++
T Consensus 196 ~~y~g~~vr~t~v~LGy~~~i~~~~p~~~~~~~~~~~tl~~~l~F~~PL~~~~~tq~~SrplVnl~vsR~l~gs~a~~~a 275 (345)
T PF07260_consen 196 ALYAGIAVRFTIVCLGYYQSIHDIIPQLSGLEKGDSATLQRMLKFWWPLALVLATQRISRPLVNLFVSRDLSGSQAATEA 275 (345)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhccccCCcccCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCcccchhh
Confidence 222222221111 11111111111222222222235678999999999999999999998888999998 4422 244
Q ss_pred HHHHHHHHH
Q 018141 184 TSLIAMCVN 192 (360)
Q Consensus 184 ~a~~~~~~~ 192 (360)
++...+..+
T Consensus 276 vavl~~~yp 284 (345)
T PF07260_consen 276 VAVLTATYP 284 (345)
T ss_pred hhhhccccC
Confidence 444443333
No 43
>PF04506 Rft-1: Rft protein; InterPro: IPR007594 Asymmetric lipid distribution is a fundamental characteristic of biological lipid bilayers, one such axample is the translocation of the Man5GlcNAc2-PP-Dol intermediate from the cytosolic side of the ER membrane to the lumen before the completion of the biosynthesis of Glc3Man9GlcNAc2-PP-Dol []. RFT1 encodes an evolutionarily conserved protein required for this translocation.; GO: 0005319 lipid transporter activity, 0006869 lipid transport, 0016021 integral to membrane
Probab=96.96 E-value=0.038 Score=52.61 Aligned_cols=124 Identities=15% Similarity=0.140 Sum_probs=98.7
Q ss_pred HHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCch---hHHH
Q 018141 3 GIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIV---IPLI 78 (360)
Q Consensus 3 ~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~---~~~~ 78 (360)
.+.+...+.+...+|+++... ...++.++..++++.-..+.+.+-++..+..+|+.+++++..++.++..+. +...
T Consensus 342 ~~~l~~ll~~~~~~gl~~~~fG~~~s~~lL~~~~g~~w~~~~~~~~l~~yc~yi~~la~NGi~EaF~~s~a~~~~l~~~~ 421 (549)
T PF04506_consen 342 ANVLSNLLKFYLYLGLVIVAFGPPYSPLLLRLLGGSRWSSTSAPSLLRAYCYYIPFLAINGITEAFVFSVASESQLDRYN 421 (549)
T ss_pred HHHHHHHHHHHHHHHHHHHHhChhhHHHHHHHHhhhcccCCCchHHHHHHHHHHHHHHHccHHHHHHHHhCCHHHHHHHH
Confidence 456777788888888888877 888888888876554334445667889999999999999999999987654 3444
Q ss_pred HHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHh
Q 018141 79 FFSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLC 127 (360)
Q Consensus 79 ~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~ 127 (360)
.......++-+..+++++.. ++|..|..+|+.+....-.++++.++++
T Consensus 422 ~~m~~~S~~f~~~~~~l~~~-~~G~~GlI~AN~iNM~lRI~ys~~fI~~ 469 (549)
T PF04506_consen 422 YWMVVFSAIFLAASYLLTRW-GLGAVGLILANCINMSLRIIYSLRFIRR 469 (549)
T ss_pred HHHHHHHHHHHHHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHHHHHH
Confidence 55666677777888888876 7899999999999999999999888853
No 44
>KOG2864 consensus Nuclear division RFT1 protein [Cell cycle control, cell division, chromosome partitioning]
Probab=96.30 E-value=0.45 Score=43.37 Aligned_cols=123 Identities=13% Similarity=0.118 Sum_probs=95.0
Q ss_pred hHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHHhcCCChHHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHcCchh---HH
Q 018141 2 LGIYLQASWITSLFFSIIISFL-WIYTEPILILLHQDPSISKQAALYMKYLIPGLVAYGVIQNILRFLQTQSIVI---PL 77 (360)
Q Consensus 2 v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~~l~~~~~~~~~~~~y~~i~~~~~~~~~~~~~~~~~l~~~~~~~---~~ 77 (360)
..+++...+-+...+|++++.. .-.+++++.+.+++.-..+.+..-+++.+..+|+.+++++..+++.+....+ ..
T Consensus 321 a~~vL~~lLklv~~igli~~~FG~~YS~~vL~lygG~kwss~~~~~lL~~YclYI~~lAiNGitEaF~~A~~t~~qi~~~ 400 (530)
T KOG2864|consen 321 AVDVLSNLLKLVIYIGLIFITFGPAYSYVVLLLYGGSKWSSGGGSLLLSWYCLYIPFLAINGITEAFAFAVATSRQIDKH 400 (530)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcCccccHHHHHHHcCccccCCCchHHHHHHHHHHHHHHhccHHHHHHHHhccHHHHHhc
Confidence 3456777777888888777776 8888999998877755555566779999999999999999999998875432 23
Q ss_pred HHHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHH
Q 018141 78 IFFSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVL 126 (360)
Q Consensus 78 ~~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~ 126 (360)
.....+..+.-.+++++++-. +|..|..+|+++...+-.++.+.+++
T Consensus 401 n~~mlafSviflilsylL~~~--~~~~GlIlANiiNm~lRIlys~~fI~ 447 (530)
T KOG2864|consen 401 NKFMLAFSVIFLILSYLLIRW--FGLVGLILANIINMSLRILYSLRFIR 447 (530)
T ss_pred ccchhHHHHHHHHHHHHHHHH--hchhHHHHHHHHHHHHHHHHHHHHHH
Confidence 344566677777888888864 45699999999998888888877774
No 45
>COG4267 Predicted membrane protein [Function unknown]
Probab=90.25 E-value=13 Score=33.37 Aligned_cols=264 Identities=13% Similarity=0.073 Sum_probs=138.4
Q ss_pred HHHHHHHcCchhHHHHHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhH
Q 018141 64 ILRFLQTQSIVIPLIFFSALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESF 143 (360)
Q Consensus 64 ~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 143 (360)
...++.+.+|.+.....-.++.++...+...+- +.+..|..++..+|..+-......+..+.-+.+++ ..++..
T Consensus 150 ~~iFlS~lK~y~~iv~sF~iG~~~sv~La~~~~---~~~ie~lLL~~~IGi~~i~~l~~~~Ilr~fk~~~~-i~FdFL-- 223 (467)
T COG4267 150 LMIFLSGLKKYKLIVLSFFIGYVVSVLLARLFL---KSPIEGLLLTLDIGIFIILFLLNFYILRYFKSSRR-IGFDFL-- 223 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH---HhHHHHHHHHHHHhHHHHHHHHHHHHHHhcccccc-cceehh--
Confidence 344567777788777777888888887776655 45889999999999998888877777543322211 111111
Q ss_pred HhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHH------HHHHHHHHHHHHH-----HHHHHHHHHHHH
Q 018141 144 SFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLI------AMCVNTESVAYMI-----TYGLSAAASTRV 212 (360)
Q Consensus 144 ~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~------~~~~~i~~~~~~~-----~~~i~~a~~~~~ 212 (360)
+..++ -....+......++..+|+.+.=.-+++++-.+.+ .+..-.......| ...+-+...+.-
T Consensus 224 ~~~~~----y~SLllIg~FY~lgiwid~FifW~~~~~~~Iag~~~~S~lYDvpiF~ayl~~iPs~vvF~i~lET~F~~~Y 299 (467)
T COG4267 224 LYRRK----YPSLLLIGFFYNLGIWIDNFIFWKVPTGIEIAGPFFASPLYDVPIFYAYLFIIPSMVVFLISLETDFQENY 299 (467)
T ss_pred hhhhc----chHHHHHHHHHHhHhhhhheeeEecCCCCEeecceecchhhhHHHHHHHHHhcchhheeeeeeeehHHHHH
Confidence 11111 12234556667777777776543322222211111 1111111111111 112233333332
Q ss_pred HHhh----cCC-------ChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHH
Q 018141 213 SNEL----GAG-------NPDQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLD 281 (360)
Q Consensus 213 ~~~~----g~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~ 281 (360)
-+.+ |.+ +.++.+...++.+.-..-+-...++.++++++.+..+++-++- .-+..++-..+.-.+
T Consensus 300 k~~y~~I~~g~tl~~I~~~~~kMiltlrq~i~~~~~lQ~~a~l~~flL~~~Ll~~~~lS~~----~l~lF~vd~lg~s~~ 375 (467)
T COG4267 300 KEYYQAIRGGGTLREIENNLKKMILTLRQGILEIMELQMLASLLCFLLADALLLWFGLSEY----YLDLFYVDVLGVSCQ 375 (467)
T ss_pred HHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChHHH----HHHHHHHHHHHHHHH
Confidence 2222 222 2333445555666666667778888899999999998876542 233344444444444
Q ss_pred hHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHH-HhCCCcceehHHHHHHHHHHH
Q 018141 282 SVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAILGF-KLSLYVKGLWIGLICGLFCQA 342 (360)
Q Consensus 282 ~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~~-~~~~g~~G~~~a~~~~~~~~~ 342 (360)
.....+-...--.++-+..+..+..- ...|..+.++... .|++-=.|.+.|..+.-.+..
T Consensus 376 i~f~~ll~i~lyfd~r~i~l~~t~~f-li~N~ilT~i~l~lgp~~~g~gff~a~fl~vlv~~ 436 (467)
T COG4267 376 IVFMSLLNIFLYFDYRRIALELTALF-LISNGILTFIFLELGPGYYGVGFFLASFLYVLVAF 436 (467)
T ss_pred HHHHHHHHHHHHHHhhhhhhhhhhHH-HHHhHHHHHHHHHhCccceehHHHHHHHHHHHHHH
Confidence 44444444444455556655555554 3556666665533 233333344444444443333
No 46
>COG4267 Predicted membrane protein [Function unknown]
Probab=82.52 E-value=38 Score=30.69 Aligned_cols=139 Identities=19% Similarity=0.126 Sum_probs=95.9
Q ss_pred HHHHHHHHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHH
Q 018141 196 VAYMITYGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLA 275 (360)
Q Consensus 196 ~~~~~~~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~ 275 (360)
+...+..+++....-.+|...=+||.++....+.-...+....+...+.+.+ +.+|+ . ...+-...+
T Consensus 72 fS~IiTgg~q~iiTRfiSD~lF~k~~~kIlpsy~Gvi~lv~~~a~~ig~~vf---------~~~~~--~--si~yk~l~~ 138 (467)
T COG4267 72 FSQIITGGFQLIITRFISDCLFEKKQRKILPSYIGVILLVTLVAGVIGLIVF---------FVNNQ--Y--SIVYKILAC 138 (467)
T ss_pred HHHHHhhhHHHHHHHHHHHHHHHHHHHHHhHhHHHHHHHHHHHHHHHHHHhh---------hhcCc--h--hHHHHHHHH
Confidence 3445567888888888888888888888877776666666655555543222 12222 1 222333445
Q ss_pred HHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHHHHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHHHHHHhc
Q 018141 276 LSITLDSVQGVLSGVARGCGWQHLAVWANLATFYFIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSLLLITLR 351 (360)
Q Consensus 276 ~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~~~~~~~ 351 (360)
...+..+...+...++.+++|.+.....-.++. ++.+.++.++-. .++.|.-++.-++..+...+...+..+
T Consensus 139 ~~FV~m~~~Wi~~iFlS~lK~y~~iv~sF~iG~-~~sv~La~~~~~---~~ie~lLL~~~IGi~~i~~l~~~~Ilr 210 (467)
T COG4267 139 ALFVGMSLVWILMIFLSGLKKYKLIVLSFFIGY-VVSVLLARLFLK---SPIEGLLLTLDIGIFIILFLLNFYILR 210 (467)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHHH---hHHHHHHHHHHHhHHHHHHHHHHHHHH
Confidence 556666777788899999999999888888884 777777776654 478999999999988877776555543
No 47
>PF04505 Dispanin: Interferon-induced transmembrane protein; InterPro: IPR007593 This family includes the human leukocyte antigen CD225, which is an interferon inducible transmembrane protein, and is associated with interferon induced cell growth suppression [].; GO: 0009607 response to biotic stimulus, 0016021 integral to membrane
Probab=64.45 E-value=25 Score=24.10 Aligned_cols=41 Identities=20% Similarity=0.221 Sum_probs=30.1
Q ss_pred HHHHHHHHHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHHH
Q 018141 202 YGLSAAASTRVSNELGAGNPDQAKNAMAVTVKLSVLLALVV 242 (360)
Q Consensus 202 ~~i~~a~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (360)
.-++-.....+-+.+.+||++++++..++..+++.+-.+..
T Consensus 34 Gi~Ai~~s~kv~~~~~~Gd~~~A~~aS~~Ak~~~~ia~~~g 74 (82)
T PF04505_consen 34 GIVAIVYSSKVRSRYAAGDYEGARRASRKAKKWSIIAIIIG 74 (82)
T ss_pred HHHHheechhhHHHHHCCCHHHHHHHHHHhHHHHHHHHHHH
Confidence 34444555667788889999999999999988876544443
No 48
>PF06808 DctM: DctM-like transporters; InterPro: IPR010656 This domain represents a conserved region located towards the N terminus of the DctM subunit of the bacterial and archaeal TRAP C4-dicarboxylate transport (Dct) system permease. In general, C4-dicarboxylate transport systems allow C4-dicarboxylates like succinate, fumarate, and malate to be taken up. TRAP C4-dicarboxylate carriers are secondary carriers that use an electrochemical H+ gradient as the driving force for transport. DctM is an integral membrane protein that is one of the constituents of TRAP carriers [, ]. Note that many family members are hypothetical proteins.
Probab=58.75 E-value=1.6e+02 Score=27.46 Aligned_cols=80 Identities=10% Similarity=0.090 Sum_probs=41.6
Q ss_pred HHhHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCC
Q 018141 140 FESFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAG 219 (360)
Q Consensus 140 ~~~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~ 219 (360)
+.++++.++..+.++|..+.-..- .-.+..|... +.|.++++...-+.-.... +++-
T Consensus 203 ~~~~~~~~~~~~~~~~~l~~p~ii-----l~~i~~g~~t--~teaa~~~~~~~l~i~~~~----------------~~~~ 259 (416)
T PF06808_consen 203 RASLKERWRAFKRAIPALLIPVII-----LGGIYLGIFT--PTEAAAVAVVYALVIGLFV----------------YRRL 259 (416)
T ss_pred cchHHHHHHHHHhcchHHHHHHHH-----HHHhhhcccc--hhhhhhhhHHHHHHHHHhh----------------hccc
Confidence 345667777777777654443322 1234455544 6666666654332211111 4445
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH
Q 018141 220 NPDQAKNAMAVTVKLSVLLALVV 242 (360)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~ 242 (360)
+.++..+..+++.+.+..+...+
T Consensus 260 ~~~~l~~~l~~~~~~~~~i~~ii 282 (416)
T PF06808_consen 260 SWKDLWRALVETARTTGMILFII 282 (416)
T ss_pred ChhhhhHHHHHHHHHHHHHHHHH
Confidence 55666666666666655444444
No 49
>PF14184 YrvL: Regulatory protein YrvL
Probab=50.80 E-value=1.1e+02 Score=23.24 Aligned_cols=91 Identities=19% Similarity=0.222 Sum_probs=59.0
Q ss_pred HHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCChHHHHHHHHHH-HHHhhhHHHHHHHHHHHHHHHHcCchhHHHHHHHHH
Q 018141 6 LQASWITSLFFSIIISFLWIYTEPILILLHQDPSISKQAALYM-KYLIPGLVAYGVIQNILRFLQTQSIVIPLIFFSALP 84 (360)
Q Consensus 6 ~~~~~~~~~~~~i~~~~~~~~~~~i~~~l~~~~~~~~~~~~y~-~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 84 (360)
+...+...++..++++...+....+.+.+|.+-|....-.-|. .....+.|+..+...+...+.-.+-++.. .....
T Consensus 4 ~~~~i~~~l~~~~v~a~~ff~~~gif~L~Gi~Y~S~~~llLF~li~~~lg~~~e~~~k~l~~~l~~~~~~~~~--~~~l~ 81 (132)
T PF14184_consen 4 FIIFIIIALLLIIVFAIYFFVMVGIFHLLGIEYESVGSLLLFFLIIFVLGLPFELFEKVLLKALLFLRMSRRL--FILLA 81 (132)
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHhCcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCchHH--HHHHH
Confidence 4455556666666666667788889999998865444433333 34577888888888777777766333332 23556
Q ss_pred HHHHHHHHHHHhhh
Q 018141 85 MAIHFGIAYAFVYL 98 (360)
Q Consensus 85 ~~~~i~l~~~~i~~ 98 (360)
..+...++..-++.
T Consensus 82 ~~id~~~t~~~i~~ 95 (132)
T PF14184_consen 82 FIIDFLFTWITIYT 95 (132)
T ss_pred HHHHHHHHHHHHHH
Confidence 66777777766664
No 50
>PF03904 DUF334: Domain of unknown function (DUF334); InterPro: IPR005602 This is a family of proteins found in Staphylococcus aureus plasmid with no characterised function.
Probab=38.41 E-value=1.8e+02 Score=24.28 Aligned_cols=56 Identities=14% Similarity=0.088 Sum_probs=34.1
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHhhHHHHHhcCCChH---------HHHHHHHHHHHHhhhHHHHH
Q 018141 4 IYLQASWITSLFFSIIISFLWIYTEPILILLHQDPS---------ISKQAALYMKYLIPGLVAYG 59 (360)
Q Consensus 4 ~~~~~~~~~~~~~~i~~~~~~~~~~~i~~~l~~~~~---------~~~~~~~y~~i~~~~~~~~~ 59 (360)
+.+..++...+++-++++++..+..|+..++|.|-. -.+....|+++++.++|-..
T Consensus 148 k~~~~gi~aml~Vf~LF~lvmt~g~d~m~fl~v~~ly~~ia~~ik~se~~~~~lwyi~Y~vPY~~ 212 (230)
T PF03904_consen 148 KSMYKGIGAMLFVFMLFALVMTIGSDFMDFLHVDHLYKAIASKIKASESFWTYLWYIAYLVPYIF 212 (230)
T ss_pred HHHHHhHHHHHHHHHHHHHHHHhcccchhhhhHHHHHHHHHHHHhhhHhHHHHHHHHHHhhHHHH
Confidence 345666777777777777777777787777774421 22234556666666665544
No 51
>PF04138 GtrA: GtrA-like protein; InterPro: IPR007267 Members of this entry belong to the GtrA family and are predicted to be integral membrane proteins with three or four transmembrane spans. They are involved in the synthesis of cell surface polysaccharides. GtrA is predicted to be an integral membrane protein with 4 transmembrane spans. It is involved in O antigen modification by Shigella flexneri bacteriophage X (SfX), but does not determine the specificity of glucosylation. Its function remains unknown, but it may play a role in translocation of undecaprenyl phosphate linked glucose (UndP-Glc) across the cytoplasmic membrane []. Another member of this family is a DTDP-glucose-4-keto-6-deoxy-D-glucose reductase, which catalyses the conversion of dTDP-4-keto-6-deoxy-D-glucose to dTDP-D-fucose, which is involved in the biosynthesis of the serotype-specific polysaccharide antigen of Actinobacillus actinomycetemcomitans Y4 (serotype b) []. This family also includes the teichoic acid glycosylation protein, GtcA, which is a serotype-specific protein in some Listeria innocua and Listeria monocytogenes strains. Its exact function is not known, but it is essential for decoration of cell wall teichoic acids with glucose and galactose [].; GO: 0000271 polysaccharide biosynthetic process, 0006810 transport, 0016021 integral to membrane
Probab=35.28 E-value=1.7e+02 Score=21.07 Aligned_cols=75 Identities=12% Similarity=0.100 Sum_probs=41.3
Q ss_pred HHHHHHHHHHHHHHhhhcCCCcchhHHHHHHHHHHHHHHHHHHHHhccccccccCCCCHHhHHhHHHHHHhHhHhHHHHH
Q 018141 82 ALPMAIHFGIAYAFVYLTSLGFKGASLAASVSLWISMLMLVTYVLCAKKFEHTWEGFSFESFSFILTILKLALPSAAMVC 161 (360)
Q Consensus 82 ~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~ 161 (360)
.++.+++...-.++... .-....+|+.++..++.+..+...+ +..+++..+. +..|+..++..-...+..
T Consensus 7 ~~~~~v~~~~~~~l~~~---~~~~~~~A~~ia~~~~~~~~f~ln~-----~~tF~~~~~~--~~~~~~~~f~~~~~~~~~ 76 (117)
T PF04138_consen 7 VIGTLVDFGVFYLLLEF---LGLNYLLANVIAFIVAIIFNFILNR-----RFTFRSRGRS--SRWRQFLRFFVVYLLGLL 76 (117)
T ss_pred HHHHHHHHHHHHHHHHH---HCcCHHHHHHHHHHHHHHHHHHHHH-----HHhccCCCCc--HHHHHHHHHHHHHHHHHH
Confidence 34445555444343322 2244677888888888777765553 2222222222 127777887777666666
Q ss_pred HHHHH
Q 018141 162 LEYWA 166 (360)
Q Consensus 162 ~~~~~ 166 (360)
.+...
T Consensus 77 ~~~~~ 81 (117)
T PF04138_consen 77 LNTLI 81 (117)
T ss_pred HHHHH
Confidence 66544
No 52
>PF13347 MFS_2: MFS/sugar transport protein
Probab=31.94 E-value=4.1e+02 Score=24.45 Aligned_cols=222 Identities=13% Similarity=0.045 Sum_probs=0.0
Q ss_pred HHcCchhHHHHHHHHHHHHHH---HHHHHHhhhcCCCcc--hhHHHHHHHHHHHHHHHHHHHHhccc--cccccCCCCHH
Q 018141 69 QTQSIVIPLIFFSALPMAIHF---GIAYAFVYLTSLGFK--GASLAASVSLWISMLMLVTYVLCAKK--FEHTWEGFSFE 141 (360)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~~~i---~l~~~~i~~~~~g~~--g~ala~~i~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 141 (360)
+.++|.+.....+..+.+-+. .+...++..++-+.. |..+...+...+..+.........|+ .+....+.+..
T Consensus 134 ~~~~R~~l~~~~~~~~~~g~~l~~~~~~~l~~~~g~~~~~~~~~~~~~v~~iv~~v~~~i~~~~~ke~~~~~~~~~~~~~ 213 (428)
T PF13347_consen 134 DPDERTRLSSWRMIFSMIGSLLASFLAPILVSWFGGGDTSNGYRWMALVLAIVGLVFFLITFFFVKERSVEVTEQEKKIS 213 (428)
T ss_pred cHhhhhhHHHHHHHHHHHHHHHHHHHhhhhhhhhccCccchHHHHHHHHHHHHHHHHhhhhhheeeeccccccccccccc
Q ss_pred hHHhHHHHH--HhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCC
Q 018141 142 SFSFILTIL--KLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAG 219 (360)
Q Consensus 142 ~~~~~~~~l--~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~ 219 (360)
-++..|+.. |.-.......+.........+...-.+. +..++.- -..........+...++....+.+++.+|++
T Consensus 214 ~~~~~~~~~~nr~~~~l~~~~~~~~~~~~~~~~~~~y~~--~~vl~~~-~~~~~~~~~~~~~~~v~~~~~~~l~~r~gk~ 290 (428)
T PF13347_consen 214 LRDSLRSLFRNRPFRILLLAFFLQWLAFALMNTFLPYYF--TYVLGNE-GLISIFMLIFFVASIVGSPLWGRLSKRFGKK 290 (428)
T ss_pred cccchhhhcccchHHHHHHHHHHHHhhhhhhhhHHHHHH--HHHhcCc-hhhHHHHHHHHHHHHHHHHHHHHHHHHccce
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHHHHHHHhhhhhhccccCCcHHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhh------
Q 018141 220 NPDQAKNAMAVTVKLSVLLALVVVLALGFGHNIWAGFFSNSPEIIKEFASLTPLLALSITLDSVQGVLSGVARG------ 293 (360)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~------ 293 (360)
+ ....+..+..+..+.+.+.++ ..............+..+........+.+
T Consensus 291 ~----------~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~i~~~l~gi~~~~~~~~~~a~~ad~id~~ 347 (428)
T PF13347_consen 291 K----------VYIIGLLLAALGFLLLFFLGP-------------GSPWLVLILFILAGIGYGAFFVIPWAMLADVIDYD 347 (428)
T ss_pred e----------ehhhhHHHHHHHHHHHHHHHh-------------hhHHHHHHHHHHhHhhhcccccccccccccchhhH
Q ss_pred ---ccchhHHHHHHHHHHHHHHHHHHH
Q 018141 294 ---CGWQHLAVWANLATFYFIGMPIAA 317 (360)
Q Consensus 294 ---~g~~~~~~~~~~~~~~~~~i~~~~ 317 (360)
.|+.+.....++-+ ....+....
T Consensus 348 e~~tg~r~~g~~~s~~~-~~~k~~~~l 373 (428)
T PF13347_consen 348 EWKTGRRREGMYFSVNS-FFIKIGQGL 373 (428)
T ss_pred HHhcCCCchHHHHHhhh-hhhHHHHHH
No 53
>PF14184 YrvL: Regulatory protein YrvL
Probab=30.69 E-value=2.4e+02 Score=21.38 Aligned_cols=111 Identities=11% Similarity=0.053 Sum_probs=62.0
Q ss_pred HHHHHHHHHHHHHHHHHhhhhhhccccCCc-HHHHHHHHHHHHHHHHHHHHHhHHHHHHHHHhhccchhHHHHHHHHHHH
Q 018141 231 TVKLSVLLALVVVLALGFGHNIWAGFFSNS-PEIIKEFASLTPLLALSITLDSVQGVLSGVARGCGWQHLAVWANLATFY 309 (360)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~i~~l~~~~-~~~~~~~~~~l~i~~~~~~~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~ 309 (360)
.......+..+.+. .++...-+.++++-+ +...+...-.+.....+.++......+...+.-.+-++.... .+. .
T Consensus 7 ~i~~~l~~~~v~a~-~ff~~~gif~L~Gi~Y~S~~~llLF~li~~~lg~~~e~~~k~l~~~l~~~~~~~~~~~-~l~--~ 82 (132)
T PF14184_consen 7 FIIIALLLIIVFAI-YFFVMVGIFHLLGIEYESVGSLLLFFLIIFVLGLPFELFEKVLLKALLFLRMSRRLFI-LLA--F 82 (132)
T ss_pred HHHHHHHHHHHHHH-HHHHHHHHHHHhCcccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccCchHHHH-HHH--H
Confidence 33444444444433 445555666777643 223444555566667788888888887666666633333222 221 3
Q ss_pred HHHHHHHHHHHHHhCCCcceehHHHHHHHHHHHHHH
Q 018141 310 FIGMPIAAILGFKLSLYVKGLWIGLICGLFCQASSL 345 (360)
Q Consensus 310 ~~~i~~~~~l~~~~~~g~~G~~~a~~~~~~~~~i~~ 345 (360)
.+....+|...+..+.=+.++++.+...-++..+..
T Consensus 83 ~id~~~t~~~i~~aD~~m~sI~is~~~e~i~al~~~ 118 (132)
T PF14184_consen 83 IIDFLFTWITIYTADELMESISISTLSEIIFALLFA 118 (132)
T ss_pred HHHHHHHHHHHHHHHHHhcceeeCcHHHHHHHHHHH
Confidence 556677777666655556777766655555544443
No 54
>TIGR00383 corA magnesium Mg(2+) and cobalt Co(2+) transport protein (corA). The article in Microb Comp Genomics 1998;3(3):151-69 (Medline:98448512) discusses this family and suggests that some members may have functions other than Mg2+ transport.
Probab=28.76 E-value=2.7e+02 Score=24.59 Aligned_cols=19 Identities=21% Similarity=0.261 Sum_probs=12.4
Q ss_pred HHHHHHHHHHHHHHhccCc
Q 018141 336 CGLFCQASSLLLITLRRKW 354 (360)
Q Consensus 336 ~~~~~~~i~~~~~~~~~~~ 354 (360)
...++.++..+++++|++|
T Consensus 299 ~~m~~i~~~~~~~fkrk~W 317 (318)
T TIGR00383 299 IVMAVIALGPLIYFRRKGW 317 (318)
T ss_pred HHHHHHHHHHHHHHHHcCC
Confidence 3334445556778888888
No 55
>COG1173 DppC ABC-type dipeptide/oligopeptide/nickel transport systems, permease components [Amino acid transport and metabolism / Inorganic ion transport and metabolism]
Probab=25.41 E-value=4.6e+02 Score=22.96 Aligned_cols=60 Identities=12% Similarity=0.032 Sum_probs=30.1
Q ss_pred hhHHHHHHHHHHHHHHHHcCchhHHHHHHHHHHHHHHHHHHHHhhhcCCCcchhHHHHHH
Q 018141 53 PGLVAYGVIQNILRFLQTQSIVIPLIFFSALPMAIHFGIAYAFVYLTSLGFKGASLAASV 112 (360)
Q Consensus 53 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~l~~~~i~~~~~g~~g~ala~~i 112 (360)
.+...........+++.+.-|.-..-+.++...+=.+++..++...++-|.....++-.+
T Consensus 98 ~~~~iG~~lG~iaGy~gG~vD~ilmri~di~ls~P~lll~i~l~~~~g~~~~~iiial~i 157 (289)
T COG1173 98 ISLVIGTLLGLLAGYFGGWVDRVLMRITDIFLAFPSLLLAILLVAILGPGLLNLILALAL 157 (289)
T ss_pred HHHHHHHHHHHHHHHcCchHHHHHHHHHHHHHHccHHHHHHHHHHHHCccHHHHHHHHHH
Confidence 333444445555666666544444444555555555555555555555444444444333
No 56
>PRK15060 L-dehydroascorbate transporter large permease subunit; Provisional
Probab=24.54 E-value=5.9e+02 Score=23.85 Aligned_cols=79 Identities=11% Similarity=0.058 Sum_probs=40.8
Q ss_pred hHHhHHHHHHhHhHhHHHHHHHHHHHHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhcCCCh
Q 018141 142 SFSFILTILKLALPSAAMVCLEYWAFEILVFLAGLMPNSELTTSLIAMCVNTESVAYMITYGLSAAASTRVSNELGAGNP 221 (360)
Q Consensus 142 ~~~~~~~~l~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~~~~~i~~a~~~~~~~~~g~~~~ 221 (360)
++++.++..+.+.|....-..- .-.+..|.+. ++|.++.+...-+.-- . .+ +++-+.
T Consensus 205 ~~~~~~~~~~~a~~~l~~pvii-----lggI~~Gi~T--pTEAaava~~yal~v~--~-----------~i---yr~l~~ 261 (425)
T PRK15060 205 TMREIWQSLVSGIWALFLPVII-----IGGFRSGLFT--PTEAGAVAAFYALFVA--V-----------VI---YREMTF 261 (425)
T ss_pred CHHHHHHHHHHHHHHHHHHHHH-----HHHHHHhccC--HHHHHHHHHHHHHHHH--H-----------HH---HcCcCH
Confidence 3455555666666643322211 1234556655 6777776655433210 0 01 334456
Q ss_pred HHHHHHHHHHHHHHHHHHHHHH
Q 018141 222 DQAKNAMAVTVKLSVLLALVVV 243 (360)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~ 243 (360)
++.++..+++.+.+..+...++
T Consensus 262 ~~l~~~l~~t~~~t~~i~~ii~ 283 (425)
T PRK15060 262 STLYHVLINAAKTTSVVMFLVA 283 (425)
T ss_pred HHHHHHHHHHHHHHHHHHHHHH
Confidence 7777777777777665554443
No 57
>PRK11085 magnesium/nickel/cobalt transporter CorA; Provisional
Probab=23.56 E-value=3e+02 Score=24.49 Aligned_cols=16 Identities=19% Similarity=0.374 Sum_probs=10.6
Q ss_pred HHHHHHHHHHHhccCc
Q 018141 339 FCQASSLLLITLRRKW 354 (360)
Q Consensus 339 ~~~~i~~~~~~~~~~~ 354 (360)
.+.++..+++++|++|
T Consensus 300 ~~~~~~~~~~f~rk~W 315 (316)
T PRK11085 300 ILAGLAPYLYFKRKNW 315 (316)
T ss_pred HHHHHHHHHHHHHccc
Confidence 3344456778888888
No 58
>PF05975 EcsB: Bacterial ABC transporter protein EcsB; InterPro: IPR010288 ABC transporters belong to the ATP-Binding Cassette (ABC) superfamily, which uses the hydrolysis of ATP to energise diverse biological systems. ABC transporters minimally consist of two conserved regions: a highly conserved ATP binding cassette (ABC) and a less conserved transmembrane domain (TMD). These can be found on the same protein or on two different ones. Most ABC transporters function as a dimer and therefore are constituted of four domains, two ABC modules and two TMDs. ABC transporters are involved in the export or import of a wide variety of substrates ranging from small ions to macromolecules. The major function of ABC import systems is to provide essential nutrients to bacteria. They are found only in prokaryotes and their four constitutive domains are usually encoded by independent polypeptides (two ABC proteins and two TMD proteins). Prokaryotic importers require additional extracytoplasmic binding proteins (one or more per systems) for function. In contrast, export systems are involved in the extrusion of noxious substances, the export of extracellular toxins and the targeting of membrane components. They are found in all living organisms and in general the TMD is fused to the ABC module in a variety of combinations. Some eukaryotic exporters encode the four domains on the same polypeptide chain []. The ABC module (approximately two hundred amino acid residues) is known to bind and hydrolyse ATP, thereby coupling transport to ATP hydrolysis in a large number of biological processes. The cassette is duplicated in several subfamilies. Its primary sequence is highly conserved, displaying a typical phosphate-binding loop: Walker A, and a magnesium binding site: Walker B. Besides these two regions, three other conserved motifs are present in the ABC cassette: the switch region which contains a histidine loop, postulated to polarise the attaching water molecule for hydrolysis, the signature conserved motif (LSGGQ) specific to the ABC transporter, and the Q-motif (between Walker A and the signature), which interacts with the gamma phosphate through a water bond. The Walker A, Walker B, Q-loop and switch region form the nucleotide binding site [, , ]. The 3D structure of a monomeric ABC module adopts a stubby L-shape with two distinct arms. ArmI (mainly beta-strand) contains Walker A and Walker B. The important residues for ATP hydrolysis and/or binding are located in the P-loop. The ATP-binding pocket is located at the extremity of armI. The perpendicular armII contains mostly the alpha helical subdomain with the signature motif. It only seems to be required for structural integrity of the ABC module. ArmII is in direct contact with the TMD. The hinge between armI and armII contains both the histidine loop and the Q-loop, making contact with the gamma phosphate of the ATP molecule. ATP hydrolysis leads to a conformational change that could facilitate ADP release. In the dimer the two ABC cassettes contact each other through hydrophobic interactions at the antiparallel beta-sheet of armI by a two-fold axis [, , , , , ]. The ATP-Binding Cassette (ABC) superfamily forms one of the largest of all protein families with a diversity of physiological functions []. Several studies have shown that there is a correlation between the functional characterisation and the phylogenetic classification of the ABC cassette [, ]. More than 50 subfamilies have been described based on a phylogenetic and functional classification [, , ]; (for further information see http://www.tcdb.org/tcdb/index.php?tc=3.A.1). This family consists of several bacterial ABC transporter proteins which are homologous to the EcsB protein of Bacillus subtilis. EcsB is thought to encode a hydrophobic protein with six membrane-spanning helices in a pattern found in other hydrophobic components of ABC transporters [].
Probab=21.23 E-value=6.4e+02 Score=23.08 Aligned_cols=37 Identities=16% Similarity=0.401 Sum_probs=29.6
Q ss_pred ChHHHHHHHHHHHHHHHHHHHHH-HHhhHHHHH-hcCCC
Q 018141 1 MLGIYLQASWITSLFFSIIISFL-WIYTEPILI-LLHQD 37 (360)
Q Consensus 1 ~v~~~~~~~~~~~~~~~i~~~~~-~~~~~~i~~-~l~~~ 37 (360)
+++++++.+...+.....+...+ ....-|+.. ..+.+
T Consensus 92 ~~~~y~~~a~~yS~~~~~~~~~~~~~ll~Pl~~~~~~~~ 130 (386)
T PF05975_consen 92 EMKQYFKRALRYSFVLQLLIQLLVFLLLLPLLMQVYGFS 130 (386)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 36789999999999999999886 777778776 44544
Done!